<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Neurochem</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Neurochem</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1471-4159</journal-id>
<journal-id journal-id-type="publisher-id">JNC</journal-id>
<journal-title-group>
<journal-title>Journal of Neurochemistry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0022-3042</issn>
<issn pub-type="epub">1471-4159</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27365114</article-id>
<article-id pub-id-type="pmc">5215415</article-id>
<article-id pub-id-type="doi">10.1111/jnc.13723</article-id>
<article-id pub-id-type="publisher-id">JNC13723</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Review</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Mini Review Series: Synaptic Function and Dysfunction in Brain Diseases</subject>
<subj-group subj-group-type="heading">
<subject>Review Articles</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Perturbed proteostasis in autism spectrum disorders</article-title>
<alt-title alt-title-type="left-running-head">S. R. Louros and E. K. Osterweil</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="jnc13723-cr-0001">
<name>
<surname>Louros</surname>
<given-names>Susana R.</given-names>
</name>
<xref ref-type="aff" rid="jnc13723-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="jnc13723-cr-0002">
<name>
<surname>Osterweil</surname>
<given-names>Emily K.</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0582-2284</contrib-id>
<address>
<email>Emily.osterweil@ed.ac.uk</email>
</address>
<xref ref-type="aff" rid="jnc13723-aff-0001">
<sup>1</sup>
</xref>
</contrib>
</contrib-group>
<aff id="jnc13723-aff-0001">
<label>
<sup>1</sup>
</label>
<institution>Centre for Integrative Physiology/Patrick Wild Centre</institution>
<institution>University of Edinburgh</institution>
<institution>Hugh Robson Building</institution>
<institution>George Square</institution>
<named-content content-type="city">Edinburgh</named-content>
<named-content content-type="country-part">EH8 9XD</named-content>
<country country="GB">UK</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label>Address correspondence and reprint requests to Emily K. Osterweil, Centre for Integrative Physiology/Patrick Wild Centre, University of Edinburgh, Hugh Robson Building, George Square, Edinburgh EH8, 9XD, UK. E‐mail: <email>Emily.osterweil@ed.ac.uk</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>04</day>
<month>8</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>12</month>
<year>2016</year>
</pub-date>
<volume>139</volume>
<issue>6</issue>
<issue-id pub-id-type="doi">10.1111/jnc.2016.139.issue-6</issue-id>
<fpage>1081</fpage>
<lpage>1092</lpage>
<history>
<date date-type="received">
<day>08</day>
<month>4</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>10</day>
<month>6</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>6</month>
<year>2016</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2016 International Society for Neurochemistry <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2016 The Authors. <italic>Journal of Neurochemistry</italic> published by John Wiley &amp; Sons Ltd on behalf of International Society for Neurochemistry</copyright-statement>
<license license-type="creativeCommonsBy">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:JNC-139-1081.pdf" xlink:type="simple"></self-uri>
<abstract id="jnc13723-abs-0001">
<title>Abstract</title>
<sec id="jnc13723-sec-0101">
<p>Dynamic changes in synaptic strength rely on <italic>de novo</italic> protein synthesis and protein degradation by the ubiquitin proteasome system (<styled-content style="fixed-case">UPS</styled-content>). Disruption of either of these cellular processes will result in significant impairments in synaptic plasticity and memory formation. Mutations in several genes encoding regulators of <styled-content style="fixed-case">mRNA</styled-content> translation and members of the <styled-content style="fixed-case">UPS</styled-content> have been associated with an increased risk for the development of autism spectrum disorders. It is possible that these mutations result in a similar imbalance in protein homeostasis (proteostasis) at the synapse. This review will summarize recent work investigating the role of the <styled-content style="fixed-case">UPS</styled-content> in synaptic plasticity at glutamatergic synapses, and propose that dysfunctional proteostasis is a common consequence of several genetic mutations linked to autism spectrum disorders.</p>
</sec>
<sec id="jnc13723-sec-0102">
<p>
<boxed-text content-type="graphic" id="jnc13723-blkfxd-0101" orientation="portrait" position="anchor"><graphic id="nlm-graphic-1" orientation="portrait" position="anchor" xlink:href="JNC-139-1081-g002.jpg"></graphic></boxed-text>
Dynamic changes in synaptic strength rely on <italic>de novo</italic> protein synthesis and protein degradation by the ubiquitin proteasome system (<styled-content style="fixed-case">UPS</styled-content>). Disruption of either of these cellular processes will result in significant impairments in synaptic plasticity and memory formation. Mutations in several genes encoding regulators of <styled-content style="fixed-case">mRNA</styled-content> translation (i.e. <italic><styled-content style="fixed-case">FMR</styled-content>1</italic>) and protein degradation (i.e. <italic><styled-content style="fixed-case">UBE</styled-content>3A</italic>) have been associated with an increased risk for autism spectrum disorders and intellectual disability (<styled-content style="fixed-case">ASD</styled-content>/<styled-content style="fixed-case">ID</styled-content>). These mutations similarly disrupt protein homeostasis (proteostasis). Compensatory changes that reset the rate of proteostasis may contribute to the neurological symptoms of <styled-content style="fixed-case">ASD</styled-content>/<styled-content style="fixed-case">ID</styled-content>. This review summarizes recent work investigating the role of the <styled-content style="fixed-case">UPS</styled-content> in synaptic plasticity at glutamatergic synapses, and proposes that dysfunctional proteostasis is a common consequence of several genetic mutations linked to <styled-content style="fixed-case">ASD</styled-content>.
</p>
<p>
<ext-link ext-link-type="uri" xlink:href="http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1471-4159/homepage/virtual_issues.htm#ISN">This article is part of a mini review series: “Synaptic Function and Dysfunction in Brain Diseases”</ext-link>.</p>
</sec>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="jnc13723-kwd-0001"><styled-content style="fixed-case">ASD</styled-content>/<styled-content style="fixed-case">ID</styled-content></kwd>
<kwd id="jnc13723-kwd-0002">autism</kwd>
<kwd id="jnc13723-kwd-0003">proteasome</kwd>
<kwd id="jnc13723-kwd-0004">synaptic plasticity</kwd>
<kwd id="jnc13723-kwd-0005">translation</kwd>
<kwd id="jnc13723-kwd-0006">ubiquitin</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>Wellcome Trust</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>Royal Society</funding-source>
<award-id>104116/Z/14/Z</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>Medical Research Council</funding-source>
<award-id>MR/M006336/1</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="2"></table-count>
<page-count count="12"></page-count>
<word-count count="10211"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>jnc13723</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>December 2016</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.0.0 mode:remove_FC converted:05.01.2017</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<def-list id="jnc13723-dl-0001" list-content="abbreviations">
<title>Abbreviations used</title>
<def-item>
<term>αCaMKII</term>
<def>
<p>αCa<sup>2+</sup>/calmodulin‐dependent kinase II</p>
</def>
</def-item>
<def-item>
<term>AMPAR</term>
<def>
<p>α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptor</p>
</def>
</def-item>
<def-item>
<term>Arc/Arg3.1</term>
<def>
<p>activity‐regulated cytoskeleton‐associated protein</p>
</def>
</def-item>
<def-item>
<term>AS</term>
<def>
<p>Angelman syndrome</p>
</def>
</def-item>
<def-item>
<term>ASD</term>
<def>
<p>autism spectrum disorders</p>
</def>
</def-item>
<def-item>
<term>BDNF</term>
<def>
<p>brain‐derived neurotropic factor</p>
</def>
</def-item>
<def-item>
<term>CA1</term>
<def>
<p>
<italic>Cornu Ammonis</italic> 1</p>
</def>
</def-item>
<def-item>
<term>Cdh1‐APC</term>
<def>
<p>anaphase‐promoting complex ubiquitin ligase</p>
</def>
</def-item>
<def-item>
<term>CNVs</term>
<def>
<p>copy number variants</p>
</def>
</def-item>
<def-item>
<term>CPEB3</term>
<def>
<p>cytoplasmic polyadenylation element binding protein 3</p>
</def>
</def-item>
<def-item>
<term>DUB</term>
<def>
<p>de‐ubiquitinase</p>
</def>
</def-item>
<def-item>
<term>FMRP</term>
<def>
<p>fragile X mental retardation protein</p>
</def>
</def-item>
<def-item>
<term>FXS</term>
<def>
<p>fragile X syndrome</p>
</def>
</def-item>
<def-item>
<term>GFP</term>
<def>
<p>green fluorescent protein</p>
</def>
</def-item>
<def-item>
<term>GKAP</term>
<def>
<p>guanylate kinase‐ associated protein</p>
</def>
</def-item>
<def-item>
<term>IA</term>
<def>
<p>inhibitory avoidance</p>
</def>
</def-item>
<def-item>
<term>ID</term>
<def>
<p>intellectual disability</p>
</def>
</def-item>
<def-item>
<term>LTD</term>
<def>
<p>long‐term depression</p>
</def>
</def-item>
<def-item>
<term>LTP</term>
<def>
<p>long‐term potentiation</p>
</def>
</def-item>
<def-item>
<term>MAPK</term>
<def>
<p>ras‐mitogen activated protein kinase</p>
</def>
</def-item>
<def-item>
<term>mGluR1/5</term>
<def>
<p>group I metabotropic glutamate receptors</p>
</def>
</def-item>
<def-item>
<term>Mib2</term>
<def>
<p>mind bomb 2 ubiquitin ligase</p>
</def>
</def-item>
<def-item>
<term>mTOR</term>
<def>
<p>mammalian target of rapamycin</p>
</def>
</def-item>
<def-item>
<term>PSD95</term>
<def>
<p>post‐synaptic density protein of 95 KDa</p>
</def>
</def-item>
<def-item>
<term>Siah1a</term>
<def>
<p>seven <italic>in absentia</italic> homolog 1A</p>
</def>
</def-item>
<def-item>
<term>SPAR</term>
<def>
<p>rap GTP activating protein</p>
</def>
</def-item>
<def-item>
<term>TSC</term>
<def>
<p>tuberous sclerosis complex</p>
</def>
</def-item>
<def-item>
<term>UPS</term>
<def>
<p>ubiquitin proteasome system</p>
</def>
</def-item>
</def-list>
<sec id="jnc13723-sec-0001">
<title>Protein synthesis and degradation in ASD/ID</title>
<p>Functioning neural circuits require synaptic connections capable of strengthening or weakening in response to activity. This plasticity, measured electrophysiologically as the long‐term potentiation or depression of synaptic strength (LTP/D), is particularly important for experience‐dependent memory formation. It is well established that <italic>de novo</italic> protein synthesis plays a fundamental role in supporting LTP/D and that it is required for the creation of new memories. Given this important role in synaptic plasticity, it is perhaps not surprising that mutations in several genes that encode regulators of protein synthesis have been identified as risk factors for the development of autism spectrum disorders with accompanying intellectual disability (ASD/ID) (Table<bold> </bold>
<xref ref-type="table-wrap" rid="jnc13723-tbl-0001">1</xref>) (Kelleher and Bear <xref ref-type="ref" rid="jnc13723-bib-0064">2008</xref>; Bhakar <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0007">2012</xref>). These include mutations in the <italic>FMR1</italic> and <italic>TSC1</italic> or <italic>TSC2</italic> genes, which respectively give rise to the neurodevelopmental disorders fragile X syndrome and tuberous sclerosis complex (TSC), as well as many regulators of the Ras‐MAPK and mammalian target of rapamycin (mTOR) translation control pathways (Kelleher and Bear <xref ref-type="ref" rid="jnc13723-bib-0064">2008</xref>; Krab <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0070">2008</xref>). Studies in animal models of these disorders reveal that protein synthesis downstream of group I metabotropic glutamate receptors (mGluR1/5) is commonly disrupted, leading to dysfunctional long‐term depression (LTD) (Dolen <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0028">2007</xref>; Krab <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0070">2008</xref>; Osterweil <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0100">2010</xref>; Auerbach <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0003">2011</xref>; Bateup <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0006">2011</xref>; Barnes <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0004">2015</xref>). Subsequent studies in multiple other mouse models of ASD/ID reveal a similar dysregulation of protein synthesis and LTD (Table<bold> </bold>
<xref ref-type="table-wrap" rid="jnc13723-tbl-0001">1</xref>). Importantly, normalizing mRNA translation corrects aberrant synaptic plasticity and several other pathological phenotypes in many of these mutant models.</p>
<table-wrap id="jnc13723-tbl-0001" orientation="portrait" position="float" xml:lang="en">
<label>Table 1</label>
<caption>
<p>ASD/ID mutations in genes encoding regulators of mRNA translation</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Gene</th>
<th align="left" colspan="1" rowspan="1" valign="top">Disorder</th>
<th align="left" colspan="1" rowspan="1" valign="top">Function</th>
<th align="left" colspan="1" rowspan="1" valign="top">Phenotypes</th>
<th align="left" colspan="1" rowspan="1" valign="top">References</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">FMR1</td>
<td align="left" colspan="1" rowspan="1">Fragile X syndrome (ID, ASD)</td>
<td align="left" colspan="1" rowspan="1">Translation repressor</td>
<td align="left" colspan="1" rowspan="1">
Enhanced mGluR‐LTD<break></break>
Impaired LTP<break></break>
Impaired learning and memory
</td>
<td align="left" colspan="1" rowspan="1">Reviewed in Bhakar <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0007">2012</xref>) and Darnell and Klann (<xref ref-type="ref" rid="jnc13723-bib-0025">2013</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CYFIP1</td>
<td align="left" colspan="1" rowspan="1">ASD</td>
<td align="left" colspan="1" rowspan="1">Translation repressor</td>
<td align="left" colspan="1" rowspan="1">
Enhanced mGluR‐LTD<break></break>
Enhanced extinction of inhibitory avoidance
</td>
<td align="left" colspan="1" rowspan="1">Nishimura <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0097">2007</xref>), Bozdagi <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0013">2012</xref>) and Wang <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0126">2015</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SYNGAP1</td>
<td align="left" colspan="1" rowspan="1">ID, ASD</td>
<td align="left" colspan="1" rowspan="1">Ras‐MAPK negative regulator</td>
<td align="left" colspan="1" rowspan="1">
Enhanced mGluR‐LTD<break></break>
Impaired LTP<break></break>
Learning and memory deficits
</td>
<td align="left" colspan="1" rowspan="1">Komiyama <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0069">2002</xref>, Barnes <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0004">2015</xref> and Jeyabalan and Clement (<xref ref-type="ref" rid="jnc13723-bib-0059">2016</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">NF1</td>
<td align="left" colspan="1" rowspan="1">
Neurofibromatosis<break></break>
type 1 (ID)
</td>
<td align="left" colspan="1" rowspan="1">Ras‐MAPK negative regulator</td>
<td align="left" colspan="1" rowspan="1">
Impaired LTP<break></break>
Abnormal spatial learning
</td>
<td align="left" colspan="1" rowspan="1">Silva <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0116">1997</xref>), Costa <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0023">2002</xref>) and Sanders <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0110">2011</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">TSC1/2</td>
<td align="left" colspan="1" rowspan="1">Tuberous sclerosis complex (ID, ASD)</td>
<td align="left" colspan="1" rowspan="1">Rheb‐mTOR negative regulator</td>
<td align="left" colspan="1" rowspan="1">
Impaired mGluR‐LTD<break></break>
Abnormal LTP<break></break>
Learning and memory deficits
</td>
<td align="left" colspan="1" rowspan="1">Ehninger <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0033">2008</xref>) and Auerbach <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0003">2011</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PTEN</td>
<td align="left" colspan="1" rowspan="1">Cowden syndrome (ID, ASD)</td>
<td align="left" colspan="1" rowspan="1">PI3K‐mTOR negative regulator</td>
<td align="left" colspan="1" rowspan="1">
Impaired LTP and LTD<break></break>
Impaired spatial memory
</td>
<td align="left" colspan="1" rowspan="1">Butler <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0015">2005</xref>), Kwon <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0074">2006</xref>) and Sperow <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0118">2012</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">RPL10</td>
<td align="left" colspan="1" rowspan="1">ID, ASD</td>
<td align="left" colspan="1" rowspan="1">Ribosomal protein</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">Klauck <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0067">2006</xref>), Brooks <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0014">2014</xref>) and Thevenon <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0124">2015</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">RPS6KA2</td>
<td align="left" colspan="1" rowspan="1">ASD</td>
<td align="left" colspan="1" rowspan="1">Ribosomal p90 S6 kinase (MAPK pathway)</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">Marshall <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0088">2008</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">RPS6KA3</td>
<td align="left" colspan="1" rowspan="1">ID, ASD</td>
<td align="left" colspan="1" rowspan="1">Ribosomal p90 S6 kinase (MAPK pathway)</td>
<td align="left" colspan="1" rowspan="1">Impaired spatial learning</td>
<td align="left" colspan="1" rowspan="1">Zeniou <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0130">2002</xref>), Zeniou‐Meyer <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0131">2010</xref>), O'Roak <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0099">2012</xref>) and Matsumoto <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0089">2013</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">EIF4E</td>
<td align="left" colspan="1" rowspan="1">ASD</td>
<td align="left" colspan="1" rowspan="1">Initiation factor</td>
<td align="left" colspan="1" rowspan="1">
Enhanced mGluR‐LTD<break></break>
Impaired social behavior<break></break>
Repetitive behaviors
</td>
<td align="left" colspan="1" rowspan="1">Neves‐Pereira <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0096">2009</xref>), Kelleher <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0065">2012</xref>), Gkogkas <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0041">2013</xref>) and Santini <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0111">2013</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">EEF1A2</td>
<td align="left" colspan="1" rowspan="1">ASD/ID</td>
<td align="left" colspan="1" rowspan="1">Elongation factor</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">de Ligt <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0081">2012</xref>) and Nakajima <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0094">2015</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">RBMS3</td>
<td align="left" colspan="1" rowspan="1">ASD</td>
<td align="left" colspan="1" rowspan="1">RNA binding protein</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">O'Roak <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0098">2011</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">HRAS</td>
<td align="left" colspan="1" rowspan="1">Costello syndrome (ASD)</td>
<td align="left" colspan="1" rowspan="1">Ras GTPase</td>
<td align="left" colspan="1" rowspan="1">
Enhanced LTP<break></break>
Enhanced spatial learning<break></break>
Enhanced fear conditioning
</td>
<td align="left" colspan="1" rowspan="1">Herault <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0050">1993</xref>, <xref ref-type="ref" rid="jnc13723-bib-0051">1995</xref>), Comings <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0021">1996</xref>), Manabe <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0086">2000</xref>), Kushner <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0073">2005</xref>), Kelleher <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0065">2012</xref>) and Alfieri <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0002">2015</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">BRAF</td>
<td align="left" colspan="1" rowspan="1">Costello syndrome/Noonan syndrome (ID, ASD)</td>
<td align="left" colspan="1" rowspan="1">MAPK activator</td>
<td align="left" colspan="1" rowspan="1">
Impaired LTP<break></break>
Impaired spatial learning<break></break>
Impaired contextual discrimination
</td>
<td align="left" colspan="1" rowspan="1">Chen <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0017">2006</xref>) and Alfieri <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0001">2014</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PTPN11</td>
<td align="left" colspan="1" rowspan="1">Noonan syndrome (ID)</td>
<td align="left" colspan="1" rowspan="1">Ras pathway regulator</td>
<td align="left" colspan="1" rowspan="1">
Impaired LTP<break></break>
Impaired spatial learning
</td>
<td align="left" colspan="1" rowspan="1">Tartaglia <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0122">2001</xref>), Lee <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0078">2014</xref>), Deciphering Developmental Disorders (<xref ref-type="ref" rid="jnc13723-bib-0026">2015</xref>) and Krumm <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0071">2015</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SOS1</td>
<td align="left" colspan="1" rowspan="1">Noonan syndrome (ID)</td>
<td align="left" colspan="1" rowspan="1">Ras pathway regulator</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">Roberts <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0108">2007</xref>) and Tartaglia <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0123">2007</xref>)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="jnc13723-note-0001">
<p>Several genetic mutations that confer risk for developing ASD or ID are found in genes related to protein synthesis. These include regulators of the Ras‐MAPK and mTOR signaling pathways that control mRNA translation at synapses. Synaptic plasticity and learning phenotypes are seen in mouse models of many of these disorders (ND = not determined).</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<p>Interestingly, the changes in protein synthesis observed in many mouse models of ASD/ID do not appear to be accompanied by significant changes in protein expression. One explanation is that there is a compensatory change in the rate of protein degradation in order to prevent large shifts in the abundance of the synaptic proteome. If so, it may be that this in itself contributes to the neurological phenotypes seen in these mutant models. Indeed, the coordination between protein synthesis and breakdown of proteins by the ubiquitin proteasome system (UPS) is thought to play an important role in the regulation of synaptic function and plasticity (Hanus and Schuman <xref ref-type="ref" rid="jnc13723-bib-0046">2013</xref>). Although the role of the UPS in neurodevelopmental disorders has received relatively little attention, one of the most commonly mutated genes linked to ASD/ID encodes the ubiquitin E3 ligase Ube3a (Kishino <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0066">1997</xref>). Moreover, mutations in over a dozen other UPS genes have been identified as risk factors for ASD/ID (Table<bold> </bold>
<xref ref-type="table-wrap" rid="jnc13723-tbl-0002">2</xref>). An intriguing possibility is that imbalance in the combined process of protein synthesis and breakdown (proteostasis) could be a common contributor to the development of ASD/ID (Fig. <xref ref-type="fig" rid="jnc13723-fig-0001">1</xref>).</p>
<table-wrap id="jnc13723-tbl-0002" orientation="portrait" position="float" xml:lang="en">
<label>Table 2</label>
<caption>
<p>ASD/ID risk factors in ubiquitin proteasome system (UPS) genes</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Gene</th>
<th align="left" colspan="1" rowspan="1" valign="top">Disorder</th>
<th align="left" colspan="1" rowspan="1" valign="top">Function</th>
<th align="left" colspan="1" rowspan="1" valign="top">Phenotypes</th>
<th align="left" colspan="1" rowspan="1" valign="top">References</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">UBE3A</td>
<td align="left" colspan="1" rowspan="1">Angelman syndrome (ID, ASD), ASD</td>
<td align="left" colspan="1" rowspan="1">E3 ubiquitin ligase</td>
<td align="left" colspan="1" rowspan="1">
Enhanced mGluR‐LTD<break></break>
Impaired LTP<break></break>
Deficits in contextual learning
</td>
<td align="left" colspan="1" rowspan="1">Jiang <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0060">1998</xref>) and Pignatelli <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0104">2014</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">UBE3B</td>
<td align="left" colspan="1" rowspan="1">ASD</td>
<td align="left" colspan="1" rowspan="1">E3 ubiquitin ligase</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">Basel‐Vanagaite <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0005">2012</xref>), Chahrour <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0016">2012</xref>) and Flex <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0036">2013</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">UBE3C</td>
<td align="left" colspan="1" rowspan="1">ASD</td>
<td align="left" colspan="1" rowspan="1">E3 ubiquitin ligase</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">O'Roak <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0099">2012</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">UBR7</td>
<td align="left" colspan="1" rowspan="1">ID</td>
<td align="left" colspan="1" rowspan="1">E3 ubiquitin ligase</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">Najmabadi <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0093">2011</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PARK2</td>
<td align="left" colspan="1" rowspan="1">ASD</td>
<td align="left" colspan="1" rowspan="1">E3 ubiquitin ligase</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">Glessner <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0042">2009</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">FBXO40</td>
<td align="left" colspan="1" rowspan="1">ASD</td>
<td align="left" colspan="1" rowspan="1">E3 ubiquitin ligase</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">Glessner <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0042">2009</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">RFWD2</td>
<td align="left" colspan="1" rowspan="1">ASD</td>
<td align="left" colspan="1" rowspan="1">E3 ubiquitin ligase</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">Glessner <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0042">2009</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Cullin 3</td>
<td align="left" colspan="1" rowspan="1">ASD</td>
<td align="left" colspan="1" rowspan="1">E3 ubiquitin ligase</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">O'Roak <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0099">2012</xref>) and Codina‐Sola <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0019">2015</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Cullin 7</td>
<td align="left" colspan="1" rowspan="1">ASD</td>
<td align="left" colspan="1" rowspan="1">E3 ubiquitin ligase</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">Krumm <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0071">2015</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">HECW2</td>
<td align="left" colspan="1" rowspan="1">ASD</td>
<td align="left" colspan="1" rowspan="1">E3 ubiquitin ligase</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">Krumm <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0071">2015</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">HERC2</td>
<td align="left" colspan="1" rowspan="1">ASD</td>
<td align="left" colspan="1" rowspan="1">E3 ubiquitin ligase</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">Puffenberger <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0106">2012</xref>) and Harlalka <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0047">2013</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">HUWE1</td>
<td align="left" colspan="1" rowspan="1">ID, ASD</td>
<td align="left" colspan="1" rowspan="1">E3 ubiquitin ligase</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">Froyen <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0038">2008</xref>, <xref ref-type="ref" rid="jnc13723-bib-0039">2012</xref>), Nava <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0095">2012</xref>) and Vandewalle <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0125">2013</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">UBL7</td>
<td align="left" colspan="1" rowspan="1">ASD</td>
<td align="left" colspan="1" rowspan="1">Ubiquitin binding protein</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">Salyakina <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0109">2011</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PSMD10</td>
<td align="left" colspan="1" rowspan="1">ASD</td>
<td align="left" colspan="1" rowspan="1">Proteasome protein</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">Piton <italic>et al</italic>. (<xref ref-type="ref" rid="jnc13723-bib-0105">2011</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">USP9Y</td>
<td align="left" colspan="1" rowspan="1">ASD</td>
<td align="left" colspan="1" rowspan="1">De‐ubiquitinase</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">ND</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">USP45</td>
<td align="left" colspan="1" rowspan="1">ASD</td>
<td align="left" colspan="1" rowspan="1">De‐ubiquitinase</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">ND</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">USP7</td>
<td align="left" colspan="1" rowspan="1">ASD</td>
<td align="left" colspan="1" rowspan="1">De‐ubiquitinase</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">ND</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="jnc13723-note-0002">
<p>Mutations in several UPS genes have been identified as risk factors for ASD or ID. These include multiple genes encoding ubiquitin E3 ligases and deubiquitinases that regulate protein degradation. With the exception of mutations in <italic>UBE3A</italic>, the functional consequences of these gene mutations have not been determined (ND).</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<fig fig-type="Figure" id="jnc13723-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<p>Dysregulation of protein synthesis or degradation results in unbalanced proteostasis. (a) Mutations in several genes that regulate <styled-content style="fixed-case">mRNA</styled-content> translation and ubiquitin proteasome system function have been implicated in <styled-content style="fixed-case">ASD</styled-content>/<styled-content style="fixed-case">ID</styled-content> (see Tables <xref ref-type="table-wrap" rid="jnc13723-tbl-0001">1</xref>, <xref ref-type="table-wrap" rid="jnc13723-tbl-0002">2</xref>). This includes regulators of translation control signaling pathways (<italic><styled-content style="fixed-case">TSC</styled-content>1/2, <styled-content style="fixed-case">NF</styled-content>1, <styled-content style="fixed-case">PTEN</styled-content>,<styled-content style="fixed-case"> SYNGAP</styled-content>1, <styled-content style="fixed-case">PTPN</styled-content>11, <styled-content style="fixed-case">HRAS</styled-content></italic>), protein synthesis regulators (<italic><styled-content style="fixed-case">FMR</styled-content>1, <styled-content style="fixed-case">CYFIP</styled-content>1, <styled-content style="fixed-case">EIF</styled-content>4E, <styled-content style="fixed-case">RBMS</styled-content>3, <styled-content style="fixed-case">RPL</styled-content>10, <styled-content style="fixed-case">RPSS</styled-content>6<styled-content style="fixed-case">KA</styled-content>2,3</italic>), E3 ubiquitin ligases (<italic><styled-content style="fixed-case">UBE</styled-content>3A,B,C, <styled-content style="fixed-case">CULLIN</styled-content>3,7, <styled-content style="fixed-case">PARK</styled-content>2, <styled-content style="fixed-case">FBXO</styled-content>40, <styled-content style="fixed-case">RFWD</styled-content>2, <styled-content style="fixed-case">HERC</styled-content>2, <styled-content style="fixed-case">HECW</styled-content>2, <styled-content style="fixed-case">HUWE</styled-content>1</italic>), de‐ubiquitinases (<italic><styled-content style="fixed-case">USP</styled-content>7, <styled-content style="fixed-case">USP</styled-content>45, <styled-content style="fixed-case">USP</styled-content>9Y</italic>), and the proteasome protein <italic><styled-content style="fixed-case">PSMD</styled-content>10</italic>. The proteins encoded by these genes collectively contribute to the proteostasis involved in synaptic plasticity. (b) The pathogenic excess in synaptic protein synthesis observed in animal models of <styled-content style="fixed-case">ASD</styled-content>/<styled-content style="fixed-case">ID</styled-content> (i.e. <italic><styled-content style="fixed-case">FMR</styled-content>1</italic>,<italic><styled-content style="fixed-case">SYNGAP</styled-content>1</italic>, and <italic><styled-content style="fixed-case">CYFIP</styled-content>1</italic>) may lead to a homeostatic increase in <styled-content style="fixed-case">UPS</styled-content> function. Similarly, mutations in E3 ligases, such as Ube3A, that decrease <styled-content style="fixed-case">UPS</styled-content> function may result in a compensatory decrease in protein synthesis. In both cases, the imbalance in proteostasis would lead to a change in the composition of new versus old plasticity related proteins (PrPs) in the synaptic proteome without necessarily affecting overall protein levels.</p>
</caption>
<graphic id="nlm-graphic-5" xlink:href="JNC-139-1081-g001"></graphic>
</fig>
<p>In this review, we will summarize work linking ubiquitination and proteasome activity to changes in synapse function. Our emphasis will be on studies investigating the role of the UPS in the plasticity of excitatory synapses that contribute to learning and memory. The links between UPS dysfunction, protein synthesis, and the development of ASD/ID will be discussed.</p>
</sec>
<sec id="jnc13723-sec-0002">
<title>UPS regulation by synaptic activity</title>
<p>The process of protein degradation is essential for the function of all eukaryotic cells, including neurons. Pathologically misfolded proteins must be removed, short‐lived proteins must be quickly degraded in response to activity, and more stable constituents must be turned over to maintain the infrastructure of the cell. The majority of cytosolic and nuclear proteins are degraded by the UPS, which is comprised of the 26S proteasome and the ubiquitin ligases that tag proteins for degradation (for extensive review see Weissman <xref ref-type="ref" rid="jnc13723-bib-0127">2001</xref>; Schmidt and Finley <xref ref-type="ref" rid="jnc13723-bib-0113">2014</xref>). The proteasome consists of multi‐subunit 19S regulatory particles, and a 20S catalytic core that hydrolyzes ATP in order to break down target proteins (Weissman <xref ref-type="ref" rid="jnc13723-bib-0127">2001</xref>). For recognition by the proteasome, proteins destined for degradation must be tagged with a polyubiquitin chain. The covalent attachment of ubiquitin to the target protein involves three different enzymes: the E1 ligase that activates monoubiquitin, the E2 ligase that conjugates additional ubiquitin monomers to form a chain, and finally the E3 ligase that selectively conjugates the polyubiquitin chain to its target protein (Schmidt and Finley <xref ref-type="ref" rid="jnc13723-bib-0113">2014</xref>; Suryadinata <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0120">2014</xref>). It is the affinity of E3 ligases for select protein targets that determines the specificity of the UPS for only those proteins that require degradation. Interestingly, the addition of a single ubiquitin to a target protein, rather than a polyubiquitin chain, may serve as a tag for intracellular trafficking rather than degradation. Generally, proteins bound to lysine 48 (K48) chains are directly targeted for proteasomal degradation while a lysine 63 (K63) chain or a single ubiquitin molecule may result in significant effects in subcellular localization or activity of proteins (Suryadinata <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0120">2014</xref>).</p>
<p>In neurons, the UPS has been implicated in several fundamental processes including morphogenesis, dendritic spine structure, synaptic activity, and the regulation of synaptic strength (for excellent reviews of these topics see Bingol and Sheng <xref ref-type="ref" rid="jnc13723-bib-0010">2011</xref>; Tai <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0121">2010</xref>; Hegde <xref ref-type="ref" rid="jnc13723-bib-0048">2010</xref>; Hamilton and Zito <xref ref-type="ref" rid="jnc13723-bib-0044">2013</xref>). Several lines of evidence show that the proteasome is regulated by neuronal activity through alterations in four factors: subunit composition, proteolytic activity, location within the cell, and interaction with other proteins. Pioneering studies in cultured neurons showed that manipulation of neuronal activity resulted in a dramatic change in the ubiquitination and degradation of the post‐synaptic proteome (Ehlers <xref ref-type="ref" rid="jnc13723-bib-0032">2003</xref>). Subsequent work revealed that proteasomes can be translocated from dendritic shafts into post‐synaptic dendritic spines within minutes upon KCl‐induced depolarization, leading to overall increased local proteolysis (Bingol and Schuman <xref ref-type="ref" rid="jnc13723-bib-0009">2006</xref>). More recent studies expressing a proteasome substrate GFP<sup>u</sup> in cultured hippocampal neurons demonstrated that proteasomal breakdown is directly related to network activity. Blockade of action potential firing with the sodium channel blocker tetrodotoxin decreased the degradation rate of GFP<sup>u</sup>, whereas increasing neuronal activity with the GABA‐A receptor antagonist bicuculline lead to more degradation (Djakovic <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0027">2009</xref>).</p>
<p>The majority of studies focused on UPS activity in synaptic function have examined excitatory neurotransmission through the activation of ion channel linked NMDA‐type glutamate receptors (NMDARs) and α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptors (AMPARs) at the post‐synaptic membrane. Experiments in cultured neurons show that agonist‐induced activation of NMDARs leads to disassembly of the 26S proteasome, resulting in decreased proteolytic activity and a dissociation of E3 ligases from the proteasome (Tai <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0121">2010</xref>). In addition, it may be that the NMDAR acts to stabilize proteasomes at synapses in order to facilitate the trafficking of AMPARs. Proteomic examination of hippocampal neurons from mice lacking the NMDAR subunit GluN2B reveals a decrease in the abundance of several proteasome subunits in purified post‐synaptic density fractions (Ferreira <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0034">2015</xref>).</p>
<p>NMDARs also regulate UPS function through the activation of the abundant post‐synaptic protein α‐Ca<sup>2+</sup>/calmodulin‐dependent kinase II (αCaMKII). Evidence from cultured neurons shows that Ca<sup>2+</sup>‐dependent activation of αCaMKII through either NMDARs or L‐type voltage‐gated Ca<sup>2+</sup> channel results in an increased association with proteasomes, and the recruitment of proteasomes into synapses (Djakovic <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0027">2009</xref>). The stimulation of proteasome activity by αCaMKII involves phosphorylation of the regulatory subunit Rpt6, which increases the catalytic activity of the 20S core (Bingol <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0011">2010</xref>). Evidence showing that αCaMKII itself can be ubiquitinated suggests that its effects on the proteasome could be autoregulatory (Na <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0092">2012</xref>), however, the specific E3 ligases regulating this process remain unknown.</p>
</sec>
<sec id="jnc13723-sec-0003">
<title>UPS regulation of the post‐synaptic proteome</title>
<p>Several studies have shown that manipulation of the UPS has a significant impact on both the structure and function of the post‐synaptic compartment. Recent studies using 2‐photon live imaging in organotypic hippocampal slice culture showed that pharmacological inhibition of the UPS dramatically reduces the rate of dendritic spine outgrowth (Hamilton <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0045">2012</xref>). This regulation of spine outgrowth by the UPS was seen to rely on the interaction between GluN2B and αCaMKII. Although the UPS substrates involved in dynamic spine morphogenesis have not been extensively characterized, the ubiquitination of the actin regulatory protein spine‐associated Rap GTP activating protein (SPAR) has been implicated in dendritic spine shrinkage and synapse weakening (Pak <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0101">2001</xref>).</p>
<p>The UPS regulates numerous proteins that have a direct impact on synaptic transmission. This includes major post‐synaptic scaffolding proteins such as post‐synaptic density protein of 95 KDa (PSD‐95), guanylate kinase‐ associated protein (GKAP) and Shank, as well as major plasticity‐related proteins (PrPs) such as Arc/Arg3.1 and αCaMKII (Ehlers <xref ref-type="ref" rid="jnc13723-bib-0032">2003</xref>). Additionally, NMDARs and AMPARs themselves are major UPS substrates, as are a number of other neurotransmitter receptors including mGluR1/5, inhibitory GABARs, kainate receptors, glycine receptors, nicotinic acetylcholine receptors, and dopamine receptors (Lin and Man <xref ref-type="ref" rid="jnc13723-bib-0082">2013</xref>). Systematic analysis of the ubiquitome in the adult rat brain using a new monoclonal antibody to purify ubiquitinated peptides followed by mass spectrometry revealed a wide range of ubiquitination events on 45 key components of the pre‐synaptic region and of the post‐synaptic density including PSD‐95, CaMKII, and receptors for AMPA, NMDA, GABA, serotonin, and acetylcholine. Interestingly, several UPS proteins were also found to be ubiquitinated, including E1, E2, E3 ligases, 10 DUBs, and several proteasome subunits (Na <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0092">2012</xref>).</p>
<p>Degradation of the NMDAR is mediated by ubiquitination of the obligatory GluN1 subunit by the E3 ligase Fbxo2, which directs receptors to cytosolic proteasomes (Kato <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0063">2005</xref>). The GluN2B subunit of the NMDAR is also ubiquitinated by the E3 ligase mind bomb 2 (Mib2) (Jurd <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0061">2008</xref>). Both mGluR1a and mGluR5 can be ubiquitinated by the E3 ligase seven in absentia homolog 1A leading to proteasomal degradation (Moriyoshi <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0091">2004</xref>). The ubiquitination of mGluR1a may be regulated by synaptic plasticity, as it has been shown to require the association with the Homer3 scaffolding protein (Rezvani <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0107">2012</xref>).</p>
<p>One of the most well‐described post‐synaptic targets of the UPS is the AMPAR. A recent study showed that all four AMPAR subunits (GluA1‐4) are rapidly ubiquitinated upon brief application of AMPA or bicuculline in cultured neurons (Widagdo <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0128">2015</xref>). The increase in neuronal activity leads to ubiquitination of GluA1 by the E3 ligase Nedd4‐1, which internalizes AMPARs and directs them to endosomes and lysosomes for degradation (Schwarz <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0114">2010</xref>). This process can be counteracted by the deubiquitinase (DUB) USP8 in response to NMDAR activation, which promotes AMPAR reinsertion into the post‐synaptic membrane (Scudder <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0115">2014</xref>). This study also reported direct modulation of E3 ligases and DUBs by synaptic activity. Upon AMPAR stimulation, Nedd4‐1 is rapidly redistributed to dendritic spines while NMDAR stimulation selectively activates USP8. Therefore, Nedd4‐1 and USP8 are regulated at synapses to control synaptic strength in an opposite fashion, regulating AMPAR ubiquitination and function. Moreover, bicuculline‐induced downscaling of AMPARs and synaptic strength is accompanied by an increase in Nedd4‐1 and a decrease in USP8 protein levels, respectively, showing that E3 ligases and DUBs can be modulated during Hebbian and homeostatic plasticity (Scudder <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0115">2014</xref>). Recently<italic>, in vivo</italic> and <italic>in vitro</italic> studies demonstrated that the DUB USP46 also targets GluA1, regulating AMPAR surface expression, endocytosis, and the strength of synaptic transmission (Huo <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0056">2015</xref>). During homeostatic plasticity, GluA1 is also targeted by the E3 ligase Cdh1‐APC and degraded by the proteasome, a process that involves signaling through ephrin receptor EphA4 (Fu <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0040">2011</xref>). Altogether, these studies indicate that ubiquitination is an important regulatory signal for controlling AMPAR function. This may explain the observed importance of the UPS for maintaining LTP and LTD, both of which occur through changes in AMPAR trafficking.</p>
</sec>
<sec id="jnc13723-sec-0004">
<title>The role of the UPS in synaptic plasticity</title>
<p>Early experiments performed in <italic>Aplysia</italic> revealed a critical role for the UPS in the long‐term facilitation of synaptic strength at sensory‐motor synapses (Hegde <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0049">1997</xref>). This observation was supported by subsequent experiments in rat hippocampal <italic>Cornu Ammonis</italic> 1 (CA1) showing that the proteasome inhibitor MG132 blocks both the early protein synthesis‐independent phase of LTP (E‐LTP), and the late‐phase LTP (L‐LTP) that requires protein synthesis (Karpova <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0062">2006</xref>). Later experiments revealed that application of the specific proteasome inhibitor lactacystin enhanced E‐LTP but blocked L‐LTP at hippocampal CA1 synapses (Fonseca <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0037">2006</xref>; Dong <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0029">2008</xref>). The specific effect of proteasome inhibitors on L‐LTP but not E‐LTP suggested that the requirement for protein degradation was related to the requirement for new protein synthesis. Further studies proved this correct, showing that the augmentation of LTP by proteasome inhibitors is blocked by the presence of the protein synthesis inhibitor anisomycin. This indicated that proteasome inhibition increases the induction of LTP by stabilizing locally translated proteins in dendrites (Dong <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0029">2008</xref>). Supporting this interpretation, a recent study linked the enhancement of E‐LTP by proteasome inhibition to increases in the levels of the translation initiation factors eIF4E and eF1A (Dong <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0030">2014</xref>). This study further suggested that proteasome inhibition might impair the consolidation of L‐LTP because of an accumulation of Paip2 and 4E‐BP2, two translational repressors (Dong <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0030">2014</xref>).</p>
<p>Another way in which the UPS may modulate LTP is in the regulation of brain‐derived neurotropic factor (BDNF). Recent work showed that application of BDNF induced a rapid and transient decrease in proteasome activity in hippocampal synaptoneurosome fractions, and that the proteasome activator IU1 blocked the enhancement of E‐LTP by BDNF (Santos <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0112">2015</xref>). Similar to previous studies, the authors show that proteasome inhibitors block the expression of L‐LTP and the effect of BDNF upon LTP consolidation (Santos <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0112">2015</xref>). These results support earlier findings, and underscore the conclusion that the combination of both the degradation and synthesis of proteins is required to support the long‐term strengthening of synapses.</p>
<p>The induction of LTD at hippocampal CA1 synapses can be induced by either the weak stimulation of NMDARs or through stimulation of mGluR1/5, both of which elicit changes in synaptic efficacy through AMPAR endocytosis (Dudek and Bear <xref ref-type="ref" rid="jnc13723-bib-0031">1992</xref>; Huber <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0055">2001</xref>). Although they can occur at the same set of synapses, a major distinction is that mGluR‐LTD requires new protein synthesis, whereas NMDAR‐LTD does not (Huber <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0054">2000</xref>). Interestingly, the role of the UPS may also differentiate these forms of LTD. Multiple studies have shown that proteasome inhibitors reduce the AMPAR endocytosis and LTD downstream of NMDAR activation (Colledge <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0020">2003</xref>; Patrick <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0102">2003</xref>; Bingol and Schuman <xref ref-type="ref" rid="jnc13723-bib-0008">2004</xref>; Citri <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0018">2009</xref>). The role of the UPS in mGluR‐LTD, however, is not as clear. Initial studies showed that incubation of hippocampal slices with the proteasome inhibitors MG132 or lactacystin resulted in impairment of mGluR‐LTD (Hou <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0052">2006</xref>). The authors proposed that the UPS sensitivity of mGluR‐LTD resulted from breakdown of the translation repressor fragile X mental retardation protein, the protein lost in fragile X syndrome (Hou <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0052">2006</xref>). Recent work identifies Cdh1‐APC as the E3 ligase responsible for fragile X mental retardation protein degradation, and shows that mice lacking this ligase exhibit impaired mGluR‐LTD (Huang <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0053">2015</xref>). Along the same lines, another recent study showed that mGluR‐LTD requires the rapid degradation of Arc/Arg3.1, a process that is counterbalanced by the RNA binding protein Sam68 (Klein <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0068">2015</xref>). Together, these results support the idea that the UPS is required for the induction of mGluR‐LTD.</p>
<p>In contrast to these results, other studies find that the UPS may be inhibitory for mGluR‐LTD. A study directly comparing both forms of LTD showed that the proteasome inhibitors MG132 and lactacystin inhibit NMDAR‐LTD but enhance mGluR‐LTD. Additionally, application of UBEI‐41/PYR‐41, a cell‐permeable compound that irreversibly inhibits the E1 activating enzyme, was shown to enhance both the AMPAR internalization and mGluR‐LTD (Citri <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0018">2009</xref>). Other work shows that application of proteasome inhibitors enhances the transition from early‐to late‐phase LTD (Li <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0080">2015</xref>). The seemingly dual nature of the UPS in LTD may result from the regulation of different target proteins: those that are ubiquitinated to facilitate the induction of LTD and those that are broken down to limit the extent of LTD. The identification of these target proteins may clarify the opposing results regarding the function of the UPS during long‐term plasticity.</p>
</sec>
<sec id="jnc13723-sec-0005">
<title>Requirement of the UPS for learning and memory</title>
<p>The key role of proteasomal degradation in the expression of long‐term synaptic plasticity has led to investigation of the UPS in learning and memory. A variety of different behavioral paradigms have been used to study the impact of synaptic plasticity on learning and memory formation. Using these paradigms, it has been shown that new mRNA translation facilitates memory formation by stabilizing molecular and synaptic changes during both consolidation (after learning) and reconsolidation (after memory reactivation) (reviewed in Jarome and Helmstetter <xref ref-type="ref" rid="jnc13723-bib-0058">2014</xref>). In order to determine the role of the UPS in these aspects of memory formation, initial studies tested the effects of lactacystin infused into the hippocampus after training on an inhibitory avoidance learning task. The results showed that lactacystin infusion resulted in a full retrograde amnesia, similar to what is seen with protein synthesis inhibitors. Concomitantly, inhibitory avoidance training resulted in an increase in protein ubiquitination and UPS activity in the hippocampus. These findings were the first to indicate that the UPS is crucial for the establishment of long‐term memory in rats (Lopez‐Salon <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0083">2001</xref>). Since then, it has been demonstrated that the inhibition of the proteasome in multiple brain regions results in impairments in memory consolidation (Jarome and Helmstetter <xref ref-type="ref" rid="jnc13723-bib-0058">2014</xref>).</p>
<p>The reconsolidation of memory is also sensitive to proteasome inhibition. Studies in the hippocampus showed that infusion of lactacystin blocked the extinction of fear conditioning and prevented the memory‐impairing effect of the protein synthesis inhibitor anisomycin when given after retrieval, but did not affect memory formation when administered after training. Based on this, the authors proposed that the UPS is required for the destabilization of pre‐existing memories, allowing for modification by reconsolidation or extinction (Lee <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0076">2008</xref>). However, this conflicts with more recent work showing that both consolidation and reconsolidation depend on protein synthesis and also on protein degradation by UPS (Figueiredo <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0035">2015</xref>).</p>
<p>Nevertheless, there is a clear relationship between the requirement for new protein synthesis and UPS function in the acquisition of memory. Indeed, the time at which memory retention is sensitive to proteasome inhibitors is the same 3–4 h post‐acquisition time window that is sensitive to protein synthesis inhibitors (Bourtchouladze <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0012">1998</xref>; Figueiredo <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0035">2015</xref>). One possibility is that the degradation of translation inhibitors is needed to promote protein synthesis‐dependent plasticity (Bingol and Sheng <xref ref-type="ref" rid="jnc13723-bib-0010">2011</xref>). It is also possible that the non‐proteolytic function of the UPS is required. Supporting this notion, the monoubiquitination of the translation regulator cytoplasmic polyadenylation element binding protein 3 was shown to be critical for the consolidation of hippocampus‐dependent memories (Pavlopoulos <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0103">2011</xref>). Further work is needed to understand the precise mechanisms by which the UPS contributes to the formation of new memories, and the potential regulation of protein synthesis.</p>
</sec>
<sec id="jnc13723-sec-0006">
<title>UPS mutations in ASD/ID</title>
<p>The impact of proteasome dysfunction on human cognition has been an active field of research with respect to neurodegenerative disorders such as Alzheimer's, Parkinson's, and Huntington's disease. In these disorders, it is widely accepted that proteasomal dysfunction is, at least in part, responsible for the formation of protein inclusions in specific neuronal subtypes that ultimately will cause neurodegeneration (Dantuma and Bott <xref ref-type="ref" rid="jnc13723-bib-0024">2014</xref>). However, very little is known about the role of the UPS in neurodevelopmental disorders.</p>
<p>One notable exception to this is Angelman syndrome (AS), a neurodevelopmental disorder caused by disruption of the E3 ligase Ube3a, which is characterized by ID, developmental delay, seizures, motor disruptions, and an unusually positive demeanor (LaSalle <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0075">2015</xref>). While the majority of cases are caused by the specific loss of the maternal <italic>UBE3A</italic> allele, several studies have shown that mutations affecting the catalytic domain of Ube3a can also result in AS symptomology (Kishino <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0066">1997</xref>; Matsuura <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0090">1997</xref>; Cooper <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0022">2004</xref>). Missense mutations targeting an inhibitory phosphorylation site on Ube3a have also been identified as risk factors for developing ASD/ID (Yi <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0129">2015</xref>). Interestingly, the duplication or triplication of the chromosomal region 15q11‐q13 in which the <italic>UBE3A</italic> gene resides is a major cytogeneic risk factor for ASD (LaSalle <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0075">2015</xref>). While it is not clear that this is due directly to the increased level of Ube3a, transgenic mice engineered to express multiple copies of the <italic>Ube3a</italic> gene exhibit impaired social behavior and communication, and increased repetitive behaviors (Smith <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0117">2011</xref>). Together, these studies strongly suggest that misregulation of Ube3a function is a causative factor in the development of ASD/ID.</p>
<p>Studies of the <italic>Ube3a</italic>
<sup>m‐/p+</sup> mouse model reveal several neuropathological changes reminiscent of AS, including deficits in synaptic plasticity in several brain regions and significant impairments in learning and memory (Mabb <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0084">2011</xref>). Given the many neurological phenotypes associated with changes in Ube3a expression, one major task in the field has been to identify brain‐derived targets as disease‐relevant substrates (LaSalle <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0075">2015</xref>). The most studied Ube3a substrate is Arc/Arg3.1, a cytoskeleton‐associated protein known to regulate trafficking of AMPARs to the membrane (Greer <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0043">2010</xref>). Interesting new work from Kuhnle and colleagues proposes an alternate mechanism by which Ube3a regulates Arc expression in immortalized cell lines. In this study, the authors suggest that Ube3a negatively regulates Arc expression at the transcription level, rather than at the posttranslational level. In fact, the use of the dihydrofolate reductase‐ubiquitin fusion protein system confirmed that over‐expression of E6AP did not significantly affect the ubiquitination status or the levels or Arc (Kuhnle <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0072">2013</xref>). Although these results have yet to be verified in neuronal cells, this is an important study because it shows a new level of regulation of Arc expression by Ube3a. However, this would seem to conflict with a recent study which demonstrated that reduction of Arc levels in the <italic>Ube3a</italic>
<sup>m−/p+</sup> mouse model ameliorated some phenotypes presented by the model of Angelman Syndrome (Mandel‐Brehm <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0087">2015</xref>). More research into the regulation of Arc is certain to reveal the relationship between these results. Indeed, Arc degradation by the UPS is also regulated by Triad3A (Mabb <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0085">2014</xref>) showing a complex mechanism of regulation of Arc protein levels.</p>
<p>Another interesting target of Ube3a is the mTOR suppressor protein Tsc2 (Zheng <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0132">2008</xref>). Recent work suggests that breakdown of Tsc2 by Ube3a may contribute to pathology in the <italic>Ube3a</italic>
<sup>m−/p+</sup> mouse of AS, as treatment with the mTOR inhibitor rapamycin rescued motor deficits and abnormal dendritic branching (Sun <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0119">2015</xref>). Despite these results, it is important to consider that the Ube3a substrates described so far contribute to only a subset of phenotypes associated with AS. It may be that the key Ube3a substrates have not yet been identified or, more likely, that the disruption of Ube3A leads to a multiplicative effect involving multiple downstream targets. Indeed, recent <italic>in vitro</italic> studies reveal that Ube3a promotes the ubiquitination of the 26S proteasome itself, suggesting that it can have a significant impact on overall UPS function (Jacobson <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0057">2014</xref>).</p>
<p>In addition to <italic>UBE3A</italic>, mutations in over a dozen other UPS genes, mainly E3 ligases, have been identified as ASD/ID risk factors (Table<bold> </bold>
<xref ref-type="table-wrap" rid="jnc13723-tbl-0002">2</xref>). Large‐scale studies have identified copy number variations that result in the deletion of the E3 ligase gene <italic>PARK2</italic>, and duplication in the E3 ligase genes <italic>RFWD2</italic> and <italic>FBXO40</italic> (Glessner <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0042">2009</xref>). A more recent study focused on rare <italic>de novo</italic> copy number variants in ASD families from the Simons Simplex Collection identified a duplication of the DUB gene <italic>USP7</italic> (Sanders <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0110">2011</xref>). The function of these genes in brain development and synaptic plasticity remains to be clarified. However, mutation of the <italic>Uba6</italic> gene encoding an E1 ubiquitin‐activating ligase has recently been shown to result in phenotypes reminiscent of ASD mouse models, including increased dendritic spine density, altered levels of Shank3 and Ube3a, and behavioral deficits including anxiety, reduced social interaction, and impaired communication (Lee <italic>et al</italic>. <xref ref-type="ref" rid="jnc13723-bib-0077">2013</xref>, <xref ref-type="ref" rid="jnc13723-bib-0079">2015</xref>). Additional studies should address the question of whether phenotypes related to ASD/ID are common neurobiological consequences of UPS gene mutation.</p>
</sec>
<sec id="jnc13723-sec-0007">
<title>Problematic proteostasis in ASD/ID</title>
<p>As large‐scale genetic studies continue to identify novel mutations linked to ASD/ID, it is becoming essential to understand the functional consequences of these mutations. Studies in mutant mouse models suggest that synaptic protein synthesis is dysregulated in several genetic causes of ASD/ID. Considering the clear functional connection between protein synthesis and breakdown, it is not unreasonable to suspect that changes in UPS function would result in similar pathology (Fig. <xref ref-type="fig" rid="jnc13723-fig-0001">1</xref>a). Evidence from the studies of <italic>UBE3A</italic> mutation illustrate that changes in UPS activity can lead to the multiple pathological changes seen in ASD/ID. However, whether other UPS gene mutations lead to neuropathology reminiscent of ASD or ID remains to be determined.</p>
<p>Another important question is whether disorders that arise because of disruption of protein synthesis also result in changes in UPS function. In this case, pathological changes would not be as a result of changes in protein levels <italic>per se</italic>, but rather an increase in protein turnover (Fig. <xref ref-type="fig" rid="jnc13723-fig-0001">1</xref>b). This could impair synaptic function by increasing the ratio of new to old proteins, which could have a drastic impact on regulation and function. Alternatively, the compensatory change in the UPS could lead to aberrant breakdown of inappropriate target proteins, or altered ubiquitin‐regulated trafficking of these targets. Teasing this apart would be of particular importance for guiding potential treatment strategies. Indeed, it is possible that the alterations in protein synthesis and compensatory changes in UPS function could contribute to different symptom domains of ASD/ID. Examination of the disruptions that occur in the collective process of proteostasis may therefore be an important next step in understanding the pathogenesis of ASD/ID.</p>
</sec>
</body>
<back>
<ack id="jnc13723-sec-0008">
<title>Acknowledgments and conflict of interest disclosure</title>
<p>The authors are grateful for support from the Wellcome Trust and Royal Society (Sir Henry Dale fellowship 104116/Z/14/Z), as well as the Medical Research Council (MRC MRC MR/M006336/1).</p>
<p>All experiments were conducted in compliance with the ARRIVE guidelines. The authors have no conflict of interest to declare.</p>
</ack>
<ref-list content-type="cited-references" id="jnc13723-bibl-0001">
<title>References</title>
<ref id="jnc13723-bib-0001">
<mixed-citation id="jnc13723-cit-0001" publication-type="journal">
<string-name>
<surname>Alfieri</surname>
<given-names>P.</given-names>
</string-name>, <string-name>
<surname>Piccini</surname>
<given-names>G.</given-names>
</string-name>, <string-name>
<surname>Caciolo</surname>
<given-names>C.</given-names>
</string-name>
<italic>et al</italic> (<year>2014</year>) <article-title>Behavioral profile in RASopathies</article-title>. <source/>Am. J. Med. Genet. A
<volume>164A</volume>, <fpage>934</fpage>–<lpage>942</lpage>.<pub-id pub-id-type="pmid">24458522</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0002">
<mixed-citation id="jnc13723-cit-0002" publication-type="journal">
<string-name>
<surname>Alfieri</surname>
<given-names>P.</given-names>
</string-name>, <string-name>
<surname>Caciolo</surname>
<given-names>C.</given-names>
</string-name>, <string-name>
<surname>Piccini</surname>
<given-names>G.</given-names>
</string-name>
<italic>et al</italic> (<year>2015</year>) <article-title>Behavioral phenotype in Costello syndrome with atypical mutation: a case report</article-title>. <source/>Am. J. Med. Genet. B Neuropsychiatr. Genet.
<volume>168B</volume>, <fpage>66</fpage>–<lpage>71</lpage>.<pub-id pub-id-type="pmid">25367099</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0003">
<mixed-citation id="jnc13723-cit-0003" publication-type="journal">
<string-name>
<surname>Auerbach</surname>
<given-names>B. D.</given-names>
</string-name>, <string-name>
<surname>Osterweil</surname>
<given-names>E. K.</given-names>
</string-name> and <string-name>
<surname>Bear</surname>
<given-names>M. F.</given-names>
</string-name> (<year>2011</year>) <article-title>Mutations causing syndromic autism define an axis of synaptic pathophysiology</article-title>. <source/>Nature
<volume>480</volume>, <fpage>63</fpage>–<lpage>68</lpage>.<pub-id pub-id-type="pmid">22113615</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0004">
<mixed-citation id="jnc13723-cit-0004" publication-type="journal">
<string-name>
<surname>Barnes</surname>
<given-names>S. A.</given-names>
</string-name>, <string-name>
<surname>Wijetunge</surname>
<given-names>L. S.</given-names>
</string-name>, <string-name>
<surname>Jackson</surname>
<given-names>A. D.</given-names>
</string-name>
<italic>et al</italic> (<year>2015</year>) <article-title>Convergence of hippocampal pathophysiology in Syngap+/‐ and Fmr1‐/y mice</article-title>. <source/>J. Neurosci.
<volume>35</volume>, <fpage>15073</fpage>–<lpage>15081</lpage>.<pub-id pub-id-type="pmid">26558778</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0005">
<mixed-citation id="jnc13723-cit-0005" publication-type="journal">
<string-name>
<surname>Basel‐Vanagaite</surname>
<given-names>L.</given-names>
</string-name>, <string-name>
<surname>Dallapiccola</surname>
<given-names>B.</given-names>
</string-name>, <string-name>
<surname>Ramirez‐Solis</surname>
<given-names>R.</given-names>
</string-name>
<italic>et al</italic> (<year>2012</year>) <article-title>Deficiency for the ubiquitin ligase UBE3B in a blepharophimosis‐ptosis‐intellectual‐disability syndrome</article-title>. <source/>Am. J. Hum. Genet.
<volume>91</volume>, <fpage>998</fpage>–<lpage>1010</lpage>.<pub-id pub-id-type="pmid">23200864</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0006">
<mixed-citation id="jnc13723-cit-0006" publication-type="journal">
<string-name>
<surname>Bateup</surname>
<given-names>H. S.</given-names>
</string-name>, <string-name>
<surname>Takasaki</surname>
<given-names>K. T.</given-names>
</string-name>, <string-name>
<surname>Saulnier</surname>
<given-names>J. L.</given-names>
</string-name>, <string-name>
<surname>Denefrio</surname>
<given-names>C. L.</given-names>
</string-name> and <string-name>
<surname>Sabatini</surname>
<given-names>B. L.</given-names>
</string-name> (<year>2011</year>) <article-title>Loss of Tsc1 in vivo impairs hippocampal mGluR‐LTD and increases excitatory synaptic function</article-title>. <source/>J. Neurosci.
<volume>31</volume>, <fpage>8862</fpage>–<lpage>8869</lpage>.<pub-id pub-id-type="pmid">21677170</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0007">
<mixed-citation id="jnc13723-cit-0007" publication-type="journal">
<string-name>
<surname>Bhakar</surname>
<given-names>A. L.</given-names>
</string-name>, <string-name>
<surname>Dolen</surname>
<given-names>G.</given-names>
</string-name> and <string-name>
<surname>Bear</surname>
<given-names>M. F.</given-names>
</string-name> (<year>2012</year>) <article-title>The pathophysiology of fragile X (and What It Teaches Us about Synapses)</article-title>. <source/>Annu. Rev. Neurosci.
<volume>35</volume>, <fpage>417</fpage>–<lpage>443</lpage>.<pub-id pub-id-type="pmid">22483044</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0008">
<mixed-citation id="jnc13723-cit-0008" publication-type="journal">
<string-name>
<surname>Bingol</surname>
<given-names>B.</given-names>
</string-name> and <string-name>
<surname>Schuman</surname>
<given-names>E. M.</given-names>
</string-name> (<year>2004</year>) <article-title>A proteasome‐sensitive connection between PSD‐95 and GluR1 endocytosis</article-title>. <source/>Neuropharmacology
<volume>47</volume>, <fpage>755</fpage>–<lpage>763</lpage>.<pub-id pub-id-type="pmid">15458847</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0009">
<mixed-citation id="jnc13723-cit-0009" publication-type="journal">
<string-name>
<surname>Bingol</surname>
<given-names>B.</given-names>
</string-name> and <string-name>
<surname>Schuman</surname>
<given-names>E. M.</given-names>
</string-name> (<year>2006</year>) <article-title>Activity‐dependent dynamics and sequestration of proteasomes in dendritic spines</article-title>. <source/>Nature
<volume>441</volume>, <fpage>1144</fpage>–<lpage>1148</lpage>.<pub-id pub-id-type="pmid">16810255</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0010">
<mixed-citation id="jnc13723-cit-0010" publication-type="journal">
<string-name>
<surname>Bingol</surname>
<given-names>B.</given-names>
</string-name> and <string-name>
<surname>Sheng</surname>
<given-names>M.</given-names>
</string-name> (<year>2011</year>) <article-title>Deconstruction for reconstruction: the role of proteolysis in neural plasticity and disease</article-title>. <source/>Neuron
<volume>69</volume>, <fpage>22</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="pmid">21220096</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0011">
<mixed-citation id="jnc13723-cit-0011" publication-type="journal">
<string-name>
<surname>Bingol</surname>
<given-names>B.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>C. F.</given-names>
</string-name>, <string-name>
<surname>Arnott</surname>
<given-names>D.</given-names>
</string-name>, <string-name>
<surname>Cheng</surname>
<given-names>D.</given-names>
</string-name>, <string-name>
<surname>Peng</surname>
<given-names>J.</given-names>
</string-name> and <string-name>
<surname>Sheng</surname>
<given-names>M.</given-names>
</string-name> (<year>2010</year>) <article-title>Autophosphorylated CaMKIIalpha acts as a scaffold to recruit proteasomes to dendritic spines</article-title>. <source/>Cell
<volume>140</volume>, <fpage>567</fpage>–<lpage>578</lpage>.<pub-id pub-id-type="pmid">20178748</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0012">
<mixed-citation id="jnc13723-cit-0012" publication-type="journal">
<string-name>
<surname>Bourtchouladze</surname>
<given-names>R.</given-names>
</string-name>, <string-name>
<surname>Abel</surname>
<given-names>T.</given-names>
</string-name>, <string-name>
<surname>Berman</surname>
<given-names>N.</given-names>
</string-name>, <string-name>
<surname>Gordon</surname>
<given-names>R.</given-names>
</string-name>, <string-name>
<surname>Lapidus</surname>
<given-names>K.</given-names>
</string-name> and <string-name>
<surname>Kandel</surname>
<given-names>E. R.</given-names>
</string-name> (<year>1998</year>) <article-title>Different training procedures recruit either one or two critical periods for contextual memory consolidation, each of which requires protein synthesis and PKA</article-title>. <source/>Learn Mem.
<volume>5</volume>, <fpage>365</fpage>–<lpage>374</lpage>.<pub-id pub-id-type="pmid">10454361</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0013">
<mixed-citation id="jnc13723-cit-0013" publication-type="journal">
<string-name>
<surname>Bozdagi</surname>
<given-names>O.</given-names>
</string-name>, <string-name>
<surname>Sakurai</surname>
<given-names>T.</given-names>
</string-name>, <string-name>
<surname>Dorr</surname>
<given-names>N.</given-names>
</string-name>, <string-name>
<surname>Pilorge</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Takahashi</surname>
<given-names>N.</given-names>
</string-name> and <string-name>
<surname>Buxbaum</surname>
<given-names>J. D.</given-names>
</string-name> (<year>2012</year>) <article-title>Haploinsufficiency of Cyfip1 produces fragile X‐like phenotypes in mice</article-title>. <source/>PLoS ONE
<volume>7</volume>, <fpage>e42422</fpage>.<pub-id pub-id-type="pmid">22900020</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0014">
<mixed-citation id="jnc13723-cit-0014" publication-type="journal">
<string-name>
<surname>Brooks</surname>
<given-names>S. S.</given-names>
</string-name>, <string-name>
<surname>Wall</surname>
<given-names>A. L.</given-names>
</string-name>, <string-name>
<surname>Golzio</surname>
<given-names>C.</given-names>
</string-name>
<italic>et al</italic> (<year>2014</year>) <article-title>A novel ribosomopathy caused by dysfunction of RPL10 disrupts neurodevelopment and causes X‐linked microcephaly in humans</article-title>. <source/>Genetics
<volume>198</volume>, <fpage>723</fpage>–<lpage>733</lpage>.<pub-id pub-id-type="pmid">25316788</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0015">
<mixed-citation id="jnc13723-cit-0015" publication-type="journal">
<string-name>
<surname>Butler</surname>
<given-names>M. G.</given-names>
</string-name>, <string-name>
<surname>Dasouki</surname>
<given-names>M. J.</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>X. P.</given-names>
</string-name>
<italic>et al</italic> (<year>2005</year>) <article-title>Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations</article-title>. <source/>J. Med. Genet.
<volume>42</volume>, <fpage>318</fpage>–<lpage>321</lpage>.<pub-id pub-id-type="pmid">15805158</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0016">
<mixed-citation id="jnc13723-cit-0016" publication-type="journal">
<string-name>
<surname>Chahrour</surname>
<given-names>M. H.</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>T. W.</given-names>
</string-name>, <string-name>
<surname>Lim</surname>
<given-names>E. T.</given-names>
</string-name>
<italic>et al</italic> (<year>2012</year>) <article-title>Whole‐exome sequencing and homozygosity analysis implicate depolarization‐regulated neuronal genes in autism</article-title>. <source/>PLoS Genet.
<volume>8</volume>, <fpage>e1002635</fpage>.<pub-id pub-id-type="pmid">22511880</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0017">
<mixed-citation id="jnc13723-cit-0017" publication-type="journal">
<string-name>
<surname>Chen</surname>
<given-names>A. P.</given-names>
</string-name>, <string-name>
<surname>Ohno</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Giese</surname>
<given-names>K. P.</given-names>
</string-name>, <string-name>
<surname>Kuhn</surname>
<given-names>R.</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>R. L.</given-names>
</string-name> and <string-name>
<surname>Silva</surname>
<given-names>A. J.</given-names>
</string-name> (<year>2006</year>) <article-title>Forebrain‐specific knockout of B‐raf kinase leads to deficits in hippocampal long‐term potentiation, learning, and memory</article-title>. <source/>J. Neurosci. Res.
<volume>83</volume>, <fpage>28</fpage>–<lpage>38</lpage>.<pub-id pub-id-type="pmid">16342120</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0018">
<mixed-citation id="jnc13723-cit-0018" publication-type="journal">
<string-name>
<surname>Citri</surname>
<given-names>A.</given-names>
</string-name>, <string-name>
<surname>Soler‐Llavina</surname>
<given-names>G.</given-names>
</string-name>, <string-name>
<surname>Bhattacharyya</surname>
<given-names>S.</given-names>
</string-name> and <string-name>
<surname>Malenka</surname>
<given-names>R. C.</given-names>
</string-name> (<year>2009</year>) <article-title>N‐methyl‐D‐aspartate receptor‐ and metabotropic glutamate receptor‐dependent long‐term depression are differentially regulated by the ubiquitin‐proteasome system</article-title>. <source/>Eur. J. Neurosci.
<volume>30</volume>, <fpage>1443</fpage>–<lpage>1450</lpage>.<pub-id pub-id-type="pmid">19821836</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0019">
<mixed-citation id="jnc13723-cit-0019" publication-type="journal">
<string-name>
<surname>Codina‐Sola</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Rodriguez‐Santiago</surname>
<given-names>B.</given-names>
</string-name>, <string-name>
<surname>Homs</surname>
<given-names>A.</given-names>
</string-name>
<italic>et al</italic> (<year>2015</year>) <article-title>Integrated analysis of whole‐exome sequencing and transcriptome profiling in males with autism spectrum disorders</article-title>. <source/>Mol. Autism
<volume>6</volume>, <fpage>21</fpage>.<pub-id pub-id-type="pmid">25969726</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0020">
<mixed-citation id="jnc13723-cit-0020" publication-type="journal">
<string-name>
<surname>Colledge</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Snyder</surname>
<given-names>E. M.</given-names>
</string-name>, <string-name>
<surname>Crozier</surname>
<given-names>R. A.</given-names>
</string-name>, <string-name>
<surname>Soderling</surname>
<given-names>J. A.</given-names>
</string-name>, <string-name>
<surname>Jin</surname>
<given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Langeberg</surname>
<given-names>L. K.</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>H.</given-names>
</string-name>, <string-name>
<surname>Bear</surname>
<given-names>M. F.</given-names>
</string-name> and <string-name>
<surname>Scott</surname>
<given-names>J. D.</given-names>
</string-name> (<year>2003</year>) <article-title>Ubiquitination regulates PSD‐95 degradation and AMPA receptor surface expression</article-title>. <source/>Neuron
<volume>40</volume>, <fpage>595</fpage>–<lpage>607</lpage>.<pub-id pub-id-type="pmid">14642282</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0021">
<mixed-citation id="jnc13723-cit-0021" publication-type="journal">
<string-name>
<surname>Comings</surname>
<given-names>D. E.</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>S.</given-names>
</string-name>, <string-name>
<surname>Chiu</surname>
<given-names>C.</given-names>
</string-name>, <string-name>
<surname>Muhleman</surname>
<given-names>D.</given-names>
</string-name> and <string-name>
<surname>Sverd</surname>
<given-names>J.</given-names>
</string-name> (<year>1996</year>) <article-title>Studies of the c‐Harvey‐Ras gene in psychiatric disorders</article-title>. <source/>Psychiatry Res.
<volume>63</volume>, <fpage>25</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="pmid">8832771</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0022">
<mixed-citation id="jnc13723-cit-0022" publication-type="journal">
<string-name>
<surname>Cooper</surname>
<given-names>E. M.</given-names>
</string-name>, <string-name>
<surname>Hudson</surname>
<given-names>A. W.</given-names>
</string-name>, <string-name>
<surname>Amos</surname>
<given-names>J.</given-names>
</string-name>, <string-name>
<surname>Wagstaff</surname>
<given-names>J.</given-names>
</string-name> and <string-name>
<surname>Howley</surname>
<given-names>P. M.</given-names>
</string-name> (<year>2004</year>) <article-title>Biochemical analysis of Angelman syndrome‐associated mutations in the E3 ubiquitin ligase E6‐associated protein</article-title>. <source/>J. Biol. Chem.
<volume>279</volume>, <fpage>41208</fpage>–<lpage>41217</lpage>.<pub-id pub-id-type="pmid">15263005</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0023">
<mixed-citation id="jnc13723-cit-0023" publication-type="journal">
<string-name>
<surname>Costa</surname>
<given-names>R. M.</given-names>
</string-name>, <string-name>
<surname>Federov</surname>
<given-names>N. B.</given-names>
</string-name>, <string-name>
<surname>Kogan</surname>
<given-names>J. H.</given-names>
</string-name>, <string-name>
<surname>Murphy</surname>
<given-names>G. G.</given-names>
</string-name>, <string-name>
<surname>Stern</surname>
<given-names>J.</given-names>
</string-name>, <string-name>
<surname>Ohno</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Kucherlapati</surname>
<given-names>R.</given-names>
</string-name>, <string-name>
<surname>Jacks</surname>
<given-names>T.</given-names>
</string-name> and <string-name>
<surname>Silva</surname>
<given-names>A. J.</given-names>
</string-name> (<year>2002</year>) <article-title>Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1</article-title>. <source/>Nature
<volume>415</volume>, <fpage>526</fpage>–<lpage>530</lpage>.<pub-id pub-id-type="pmid">11793011</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0024">
<mixed-citation id="jnc13723-cit-0024" publication-type="journal">
<string-name>
<surname>Dantuma</surname>
<given-names>N. P.</given-names>
</string-name> and <string-name>
<surname>Bott</surname>
<given-names>L. C.</given-names>
</string-name> (<year>2014</year>) <article-title>The ubiquitin‐proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution</article-title>. <source/>Front Mol. Neurosci.
<volume>7</volume>, <fpage>70</fpage>.<pub-id pub-id-type="pmid">25132814</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0025">
<mixed-citation id="jnc13723-cit-0025" publication-type="journal">
<string-name>
<surname>Darnell</surname>
<given-names>J. C.</given-names>
</string-name> and <string-name>
<surname>Klann</surname>
<given-names>E.</given-names>
</string-name> (<year>2013</year>) <article-title>The translation of translational control by FMRP: therapeutic targets for FXS</article-title>. <source/>Nat. Neurosci.
<volume>16</volume>, <fpage>1530</fpage>–<lpage>1536</lpage>.<pub-id pub-id-type="pmid">23584741</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0026">
<mixed-citation id="jnc13723-cit-0026" publication-type="journal">
<collab collab-type="authors">Deciphering Developmental Disorders, S.</collab>
(<year>2015</year>) <article-title>Large‐scale discovery of novel genetic causes of developmental disorders</article-title>. <source/>Nature, <volume>519</volume>, <fpage>223</fpage>–<lpage>228</lpage>.<pub-id pub-id-type="pmid">25533962</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0027">
<mixed-citation id="jnc13723-cit-0027" publication-type="journal">
<string-name>
<surname>Djakovic</surname>
<given-names>S. N.</given-names>
</string-name>, <string-name>
<surname>Schwarz</surname>
<given-names>L. A.</given-names>
</string-name>, <string-name>
<surname>Barylko</surname>
<given-names>B.</given-names>
</string-name>, <string-name>
<surname>DeMartino</surname>
<given-names>G. N.</given-names>
</string-name> and <string-name>
<surname>Patrick</surname>
<given-names>G. N.</given-names>
</string-name> (<year>2009</year>) <article-title>Regulation of the proteasome by neuronal activity and calcium/calmodulin‐dependent protein kinase II</article-title>. <source/>J. Biol. Chem.
<volume>284</volume>, <fpage>26655</fpage>–<lpage>26665</lpage>.<pub-id pub-id-type="pmid">19638347</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0028">
<mixed-citation id="jnc13723-cit-0028" publication-type="journal">
<string-name>
<surname>Dolen</surname>
<given-names>G.</given-names>
</string-name>, <string-name>
<surname>Osterweil</surname>
<given-names>E.</given-names>
</string-name>, <string-name>
<surname>Rao</surname>
<given-names>B. S.</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>G. B.</given-names>
</string-name>, <string-name>
<surname>Auerbach</surname>
<given-names>B. D.</given-names>
</string-name>, <string-name>
<surname>Chattarji</surname>
<given-names>S.</given-names>
</string-name> and <string-name>
<surname>Bear</surname>
<given-names>M. F.</given-names>
</string-name> (<year>2007</year>) <article-title>Correction of fragile X syndrome in mice</article-title>. <source/>Neuron
<volume>56</volume>, <fpage>955</fpage>–<lpage>962</lpage>.<pub-id pub-id-type="pmid">18093519</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0029">
<mixed-citation id="jnc13723-cit-0029" publication-type="journal">
<string-name>
<surname>Dong</surname>
<given-names>C.</given-names>
</string-name>, <string-name>
<surname>Upadhya</surname>
<given-names>S. C.</given-names>
</string-name>, <string-name>
<surname>Ding</surname>
<given-names>L.</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>T. K.</given-names>
</string-name> and <string-name>
<surname>Hegde</surname>
<given-names>A. N.</given-names>
</string-name> (<year>2008</year>) <article-title>Proteasome inhibition enhances the induction and impairs the maintenance of late‐phase long‐term potentiation</article-title>. <source/>Learn Mem.
<volume>15</volume>, <fpage>335</fpage>–<lpage>347</lpage>.<pub-id pub-id-type="pmid">18441292</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0030">
<mixed-citation id="jnc13723-cit-0030" publication-type="journal">
<string-name>
<surname>Dong</surname>
<given-names>C.</given-names>
</string-name>, <string-name>
<surname>Bach</surname>
<given-names>S. V.</given-names>
</string-name>, <string-name>
<surname>Haynes</surname>
<given-names>K. A.</given-names>
</string-name> and <string-name>
<surname>Hegde</surname>
<given-names>A. N.</given-names>
</string-name> (<year>2014</year>) <article-title>Proteasome modulates positive and negative translational regulators in long‐term synaptic plasticity</article-title>. <source/>J. Neurosci.
<volume>34</volume>, <fpage>3171</fpage>–<lpage>3182</lpage>.<pub-id pub-id-type="pmid">24573276</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0031">
<mixed-citation id="jnc13723-cit-0031" publication-type="journal">
<string-name>
<surname>Dudek</surname>
<given-names>S. M.</given-names>
</string-name> and <string-name>
<surname>Bear</surname>
<given-names>M. F.</given-names>
</string-name> (<year>1992</year>) <article-title>Homosynaptic long‐term depression in area CA1 of hippocampus and effects of N‐methyl‐D‐aspartate receptor blockade</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>89</volume>, <fpage>4363</fpage>–<lpage>4367</lpage>.<pub-id pub-id-type="pmid">1350090</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0032">
<mixed-citation id="jnc13723-cit-0032" publication-type="journal">
<string-name>
<surname>Ehlers</surname>
<given-names>M. D.</given-names>
</string-name> (<year>2003</year>) <article-title>Activity level controls postsynaptic composition and signaling via the ubiquitin‐proteasome system</article-title>. <source/>Nat. Neurosci.
<volume>6</volume>, <fpage>231</fpage>–<lpage>242</lpage>.<pub-id pub-id-type="pmid">12577062</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0033">
<mixed-citation id="jnc13723-cit-0033" publication-type="journal">
<string-name>
<surname>Ehninger</surname>
<given-names>D.</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>S.</given-names>
</string-name>, <string-name>
<surname>Shilyansky</surname>
<given-names>C.</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>W.</given-names>
</string-name>, <string-name>
<surname>Kwiatkowski</surname>
<given-names>D. J.</given-names>
</string-name>, <string-name>
<surname>Ramesh</surname>
<given-names>V.</given-names>
</string-name> and <string-name>
<surname>Silva</surname>
<given-names>A. J.</given-names>
</string-name> (<year>2008</year>) <article-title>Reversal of learning deficits in a Tsc2 + /‐ mouse model of tuberous sclerosis</article-title>. <source/>Nat. Med.
<volume>14</volume>, <fpage>843</fpage>–<lpage>848</lpage>.<pub-id pub-id-type="pmid">18568033</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0034">
<mixed-citation id="jnc13723-cit-0034" publication-type="journal">
<string-name>
<surname>Ferreira</surname>
<given-names>J. S.</given-names>
</string-name>, <string-name>
<surname>Schmidt</surname>
<given-names>J.</given-names>
</string-name>, <string-name>
<surname>Rio</surname>
<given-names>P.</given-names>
</string-name>, <string-name>
<surname>Aguas</surname>
<given-names>R.</given-names>
</string-name>, <string-name>
<surname>Rooyakkers</surname>
<given-names>A.</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>K. W.</given-names>
</string-name>, <string-name>
<surname>Smit</surname>
<given-names>A. B.</given-names>
</string-name>, <string-name>
<surname>Craig</surname>
<given-names>A. M.</given-names>
</string-name> and <string-name>
<surname>Carvalho</surname>
<given-names>A. L.</given-names>
</string-name> (<year>2015</year>) <article-title>GluN2B‐containing NMDA receptors regulate AMPA receptor traffic through anchoring of the synaptic proteasome</article-title>. <source/>J. Neurosci.
<volume>35</volume>, <fpage>8462</fpage>–<lpage>8479</lpage>.<pub-id pub-id-type="pmid">26041915</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0035">
<mixed-citation id="jnc13723-cit-0035" publication-type="journal">
<string-name>
<surname>Figueiredo</surname>
<given-names>L. S.</given-names>
</string-name>, <string-name>
<surname>Dornelles</surname>
<given-names>A. S.</given-names>
</string-name>, <string-name>
<surname>Petry</surname>
<given-names>F. S.</given-names>
</string-name>, <string-name>
<surname>Falavigna</surname>
<given-names>L.</given-names>
</string-name>, <string-name>
<surname>Dargel</surname>
<given-names>V. A.</given-names>
</string-name>, <string-name>
<surname>Kobe</surname>
<given-names>L. M.</given-names>
</string-name>, <string-name>
<surname>Aguzzoli</surname>
<given-names>C.</given-names>
</string-name>, <string-name>
<surname>Roesler</surname>
<given-names>R.</given-names>
</string-name> and <string-name>
<surname>Schroder</surname>
<given-names>N.</given-names>
</string-name> (<year>2015</year>) <article-title>Two waves of proteasome‐dependent protein degradation in the hippocampus are required for recognition memory consolidation</article-title>. <source/>Neurobiol. Learn. Mem.
<volume>120</volume>, <fpage>1</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">25687693</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0036">
<mixed-citation id="jnc13723-cit-0036" publication-type="journal">
<string-name>
<surname>Flex</surname>
<given-names>E.</given-names>
</string-name>, <string-name>
<surname>Ciolfi</surname>
<given-names>A.</given-names>
</string-name>, <string-name>
<surname>Caputo</surname>
<given-names>V.</given-names>
</string-name>
<italic>et al</italic> (<year>2013</year>) <article-title>Loss of function of the E3 ubiquitin‐protein ligase UBE3B causes Kaufman oculocerebrofacial syndrome</article-title>. <source/>J. Med. Genet.
<volume>50</volume>, <fpage>493</fpage>–<lpage>499</lpage>.<pub-id pub-id-type="pmid">23687348</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0037">
<mixed-citation id="jnc13723-cit-0037" publication-type="journal">
<string-name>
<surname>Fonseca</surname>
<given-names>R.</given-names>
</string-name>, <string-name>
<surname>Vabulas</surname>
<given-names>R. M.</given-names>
</string-name>, <string-name>
<surname>Hartl</surname>
<given-names>F. U.</given-names>
</string-name>, <string-name>
<surname>Bonhoeffer</surname>
<given-names>T.</given-names>
</string-name> and <string-name>
<surname>Nagerl</surname>
<given-names>U. V.</given-names>
</string-name> (<year>2006</year>) <article-title>A balance of protein synthesis and proteasome‐dependent degradation determines the maintenance of LTP</article-title>. <source/>Neuron
<volume>52</volume>, <fpage>239</fpage>–<lpage>245</lpage>.<pub-id pub-id-type="pmid">17046687</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0038">
<mixed-citation id="jnc13723-cit-0038" publication-type="journal">
<string-name>
<surname>Froyen</surname>
<given-names>G.</given-names>
</string-name>, <string-name>
<surname>Corbett</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Vandewalle</surname>
<given-names>J.</given-names>
</string-name>
<italic>et al</italic> (<year>2008</year>) <article-title>Submicroscopic duplications of the hydroxysteroid dehydrogenase HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated with mental retardation</article-title>. <source/>Am. J. Hum. Genet.
<volume>82</volume>, <fpage>432</fpage>–<lpage>443</lpage>.<pub-id pub-id-type="pmid">18252223</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0039">
<mixed-citation id="jnc13723-cit-0039" publication-type="journal">
<string-name>
<surname>Froyen</surname>
<given-names>G.</given-names>
</string-name>, <string-name>
<surname>Belet</surname>
<given-names>S.</given-names>
</string-name>, <string-name>
<surname>Martinez</surname>
<given-names>F.</given-names>
</string-name>
<italic>et al</italic> (<year>2012</year>) <article-title>Copy‐number gains of HUWE1 due to replication‐ and recombination‐based rearrangements</article-title>. <source/>Am. J. Hum. Genet.
<volume>91</volume>, <fpage>252</fpage>–<lpage>264</lpage>.<pub-id pub-id-type="pmid">22840365</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0040">
<mixed-citation id="jnc13723-cit-0040" publication-type="journal">
<string-name>
<surname>Fu</surname>
<given-names>A. K.</given-names>
</string-name>, <string-name>
<surname>Hung</surname>
<given-names>K. W.</given-names>
</string-name>, <string-name>
<surname>Fu</surname>
<given-names>W. Y.</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>C.</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Xia</surname>
<given-names>J.</given-names>
</string-name>, <string-name>
<surname>Lai</surname>
<given-names>K. O.</given-names>
</string-name> and <string-name>
<surname>Ip</surname>
<given-names>N. Y.</given-names>
</string-name> (<year>2011</year>) <article-title>APC(Cdh1) mediates EphA4‐dependent downregulation of AMPA receptors in homeostatic plasticity</article-title>. <source/>Nat. Neurosci.
<volume>14</volume>, <fpage>181</fpage>–<lpage>189</lpage>.<pub-id pub-id-type="pmid">21186356</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0041">
<mixed-citation id="jnc13723-cit-0041" publication-type="journal">
<string-name>
<surname>Gkogkas</surname>
<given-names>C. G.</given-names>
</string-name>, <string-name>
<surname>Khoutorsky</surname>
<given-names>A.</given-names>
</string-name>, <string-name>
<surname>Ran</surname>
<given-names>I.</given-names>
</string-name>
<italic>et al</italic> (<year>2013</year>) <article-title>Autism‐related deficits via dysregulated eIF4E‐dependent translational control</article-title>. <source/>Nature
<volume>493</volume>, <fpage>371</fpage>–<lpage>377</lpage>.<pub-id pub-id-type="pmid">23172145</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0042">
<mixed-citation id="jnc13723-cit-0042" publication-type="journal">
<string-name>
<surname>Glessner</surname>
<given-names>J. T.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>K.</given-names>
</string-name>, <string-name>
<surname>Cai</surname>
<given-names>G.</given-names>
</string-name>
<italic>et al</italic> (<year>2009</year>) <article-title>Autism genome‐wide copy number variation reveals ubiquitin and neuronal genes</article-title>. <source/>Nature
<volume>459</volume>, <fpage>569</fpage>–<lpage>573</lpage>.<pub-id pub-id-type="pmid">19404257</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0043">
<mixed-citation id="jnc13723-cit-0043" publication-type="journal">
<string-name>
<surname>Greer</surname>
<given-names>P. L.</given-names>
</string-name>, <string-name>
<surname>Hanayama</surname>
<given-names>R.</given-names>
</string-name>, <string-name>
<surname>Bloodgood</surname>
<given-names>B. L.</given-names>
</string-name>
<italic>et al</italic> (<year>2010</year>) <article-title>The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc</article-title>. <source/>Cell
<volume>140</volume>, <fpage>704</fpage>–<lpage>716</lpage>.<pub-id pub-id-type="pmid">20211139</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0044">
<mixed-citation id="jnc13723-cit-0044" publication-type="journal">
<string-name>
<surname>Hamilton</surname>
<given-names>A. M.</given-names>
</string-name> and <string-name>
<surname>Zito</surname>
<given-names>K.</given-names>
</string-name> (<year>2013</year>) <article-title>Breaking it down: the ubiquitin proteasome system in neuronal morphogenesis</article-title>. <source/>Neural. Plast.
<volume>2013</volume>, <fpage>196848</fpage>.<pub-id pub-id-type="pmid">23476809</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0045">
<mixed-citation id="jnc13723-cit-0045" publication-type="journal">
<string-name>
<surname>Hamilton</surname>
<given-names>A. M.</given-names>
</string-name>, <string-name>
<surname>Oh</surname>
<given-names>W. C.</given-names>
</string-name>, <string-name>
<surname>Vega‐Ramirez</surname>
<given-names>H.</given-names>
</string-name>, <string-name>
<surname>Stein</surname>
<given-names>I. S.</given-names>
</string-name>, <string-name>
<surname>Hell</surname>
<given-names>J. W.</given-names>
</string-name>, <string-name>
<surname>Patrick</surname>
<given-names>G. N.</given-names>
</string-name> and <string-name>
<surname>Zito</surname>
<given-names>K.</given-names>
</string-name> (<year>2012</year>) <article-title>Activity‐dependent growth of new dendritic spines is regulated by the proteasome</article-title>. <source/>Neuron
<volume>74</volume>, <fpage>1023</fpage>–<lpage>1030</lpage>.<pub-id pub-id-type="pmid">22726833</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0046">
<mixed-citation id="jnc13723-cit-0046" publication-type="journal">
<string-name>
<surname>Hanus</surname>
<given-names>C.</given-names>
</string-name> and <string-name>
<surname>Schuman</surname>
<given-names>E. M.</given-names>
</string-name> (<year>2013</year>) <article-title>Proteostasis in complex dendrites</article-title>. <source/>Nat. Rev. Neurosci.
<volume>14</volume>, <fpage>638</fpage>–<lpage>648</lpage>.<pub-id pub-id-type="pmid">23900412</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0047">
<mixed-citation id="jnc13723-cit-0047" publication-type="journal">
<string-name>
<surname>Harlalka</surname>
<given-names>G. V.</given-names>
</string-name>, <string-name>
<surname>Baple</surname>
<given-names>E. L.</given-names>
</string-name>, <string-name>
<surname>Cross</surname>
<given-names>H.</given-names>
</string-name>
<italic>et al</italic> (<year>2013</year>) <article-title>Mutation of HERC2 causes developmental delay with Angelman‐like features</article-title>. <source/>J. Med. Genet.
<volume>50</volume>, <fpage>65</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="pmid">23243086</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0048">
<mixed-citation id="jnc13723-cit-0048" publication-type="journal">
<string-name>
<surname>Hegde</surname>
<given-names>A. N.</given-names>
</string-name> (<year>2010</year>) <article-title>The ubiquitin‐proteasome pathway and synaptic plasticity</article-title>. <source/>Learn Mem.
<volume>17</volume>, <fpage>314</fpage>–<lpage>327</lpage>.<pub-id pub-id-type="pmid">20566674</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0049">
<mixed-citation id="jnc13723-cit-0049" publication-type="journal">
<string-name>
<surname>Hegde</surname>
<given-names>A. N.</given-names>
</string-name>, <string-name>
<surname>Inokuchi</surname>
<given-names>K.</given-names>
</string-name>, <string-name>
<surname>Pei</surname>
<given-names>W.</given-names>
</string-name>, <string-name>
<surname>Casadio</surname>
<given-names>A.</given-names>
</string-name>, <string-name>
<surname>Ghirardi</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Chain</surname>
<given-names>D. G.</given-names>
</string-name>, <string-name>
<surname>Martin</surname>
<given-names>K. C.</given-names>
</string-name>, <string-name>
<surname>Kandel</surname>
<given-names>E. R.</given-names>
</string-name> and <string-name>
<surname>Schwartz</surname>
<given-names>J. H.</given-names>
</string-name> (<year>1997</year>) <article-title>Ubiquitin C‐terminal hydrolase is an immediate‐early gene essential for long‐term facilitation in Aplysia</article-title>. <source/>Cell
<volume>89</volume>, <fpage>115</fpage>–<lpage>126</lpage>.<pub-id pub-id-type="pmid">9094720</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0050">
<mixed-citation id="jnc13723-cit-0050" publication-type="journal">
<string-name>
<surname>Herault</surname>
<given-names>J.</given-names>
</string-name>, <string-name>
<surname>Perrot</surname>
<given-names>A.</given-names>
</string-name>, <string-name>
<surname>Barthelemy</surname>
<given-names>C.</given-names>
</string-name>
<italic>et al</italic> (<year>1993</year>) <article-title>Possible association of c‐Harvey‐Ras‐1 (HRAS‐1) marker with autism</article-title>. <source/>Psychiatry Res.
<volume>46</volume>, <fpage>261</fpage>–<lpage>267</lpage>.<pub-id pub-id-type="pmid">8098541</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0051">
<mixed-citation id="jnc13723-cit-0051" publication-type="journal">
<string-name>
<surname>Herault</surname>
<given-names>J.</given-names>
</string-name>, <string-name>
<surname>Petit</surname>
<given-names>E.</given-names>
</string-name>, <string-name>
<surname>Martineau</surname>
<given-names>J.</given-names>
</string-name>
<italic>et al</italic> (<year>1995</year>) <article-title>Autism and genetics: clinical approach and association study with two markers of HRAS gene</article-title>. <source/>Am. J. Med. Genet.
<volume>60</volume>, <fpage>276</fpage>–<lpage>281</lpage>.<pub-id pub-id-type="pmid">7485261</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0052">
<mixed-citation id="jnc13723-cit-0052" publication-type="journal">
<string-name>
<surname>Hou</surname>
<given-names>L.</given-names>
</string-name>, <string-name>
<surname>Antion</surname>
<given-names>M. D.</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>D.</given-names>
</string-name>, <string-name>
<surname>Spencer</surname>
<given-names>C. M.</given-names>
</string-name>, <string-name>
<surname>Paylor</surname>
<given-names>R.</given-names>
</string-name> and <string-name>
<surname>Klann</surname>
<given-names>E.</given-names>
</string-name> (<year>2006</year>) <article-title>Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR‐dependent long‐term depression</article-title>. <source/>Neuron
<volume>51</volume>, <fpage>441</fpage>–<lpage>454</lpage>.<pub-id pub-id-type="pmid">16908410</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0053">
<mixed-citation id="jnc13723-cit-0053" publication-type="journal">
<string-name>
<surname>Huang</surname>
<given-names>J.</given-names>
</string-name>, <string-name>
<surname>Ikeuchi</surname>
<given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Malumbres</surname>
<given-names>M.</given-names>
</string-name> and <string-name>
<surname>Bonni</surname>
<given-names>A.</given-names>
</string-name> (<year>2015</year>) <article-title>A Cdh1‐APC/FMRP ubiquitin signaling link drives mGluR‐dependent synaptic plasticity in the mammalian brain</article-title>. <source/>Neuron
<volume>86</volume>, <fpage>726</fpage>–<lpage>739</lpage>.<pub-id pub-id-type="pmid">25913861</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0054">
<mixed-citation id="jnc13723-cit-0054" publication-type="journal">
<string-name>
<surname>Huber</surname>
<given-names>K. M.</given-names>
</string-name>, <string-name>
<surname>Kayser</surname>
<given-names>M. S.</given-names>
</string-name> and <string-name>
<surname>Bear</surname>
<given-names>M. F.</given-names>
</string-name> (<year>2000</year>) <article-title>Role for rapid dendritic protein synthesis in hippocampal mGluR‐dependent long‐term depression</article-title>. <source/>Science
<volume>288</volume>, <fpage>1254</fpage>–<lpage>1257</lpage>.<pub-id pub-id-type="pmid">10818003</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0055">
<mixed-citation id="jnc13723-cit-0055" publication-type="journal">
<string-name>
<surname>Huber</surname>
<given-names>K. M.</given-names>
</string-name>, <string-name>
<surname>Roder</surname>
<given-names>J. C.</given-names>
</string-name> and <string-name>
<surname>Bear</surname>
<given-names>M. F.</given-names>
</string-name> (<year>2001</year>) <article-title>Chemical induction of mGluR5‐ and protein synthesis–dependent long‐term depression in hippocampal area CA1</article-title>. <source/>J. Neurophysiol.
<volume>86</volume>, <fpage>321</fpage>–<lpage>325</lpage>.<pub-id pub-id-type="pmid">11431513</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0056">
<mixed-citation id="jnc13723-cit-0056" publication-type="journal">
<string-name>
<surname>Huo</surname>
<given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Khatri</surname>
<given-names>N.</given-names>
</string-name>, <string-name>
<surname>Hou</surname>
<given-names>Q.</given-names>
</string-name>, <string-name>
<surname>Gilbert</surname>
<given-names>J.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>G.</given-names>
</string-name> and <string-name>
<surname>Man</surname>
<given-names>H. Y.</given-names>
</string-name> (<year>2015</year>) <article-title>The deubiquitinating enzyme USP46 regulates AMPA receptor ubiquitination and trafficking</article-title>. <source/>J. Neurochem.
<volume>134</volume>, <fpage>1067</fpage>–<lpage>1080</lpage>.<pub-id pub-id-type="pmid">26077708</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0057">
<mixed-citation id="jnc13723-cit-0057" publication-type="journal">
<string-name>
<surname>Jacobson</surname>
<given-names>A. D.</given-names>
</string-name>, <string-name>
<surname>MacFadden</surname>
<given-names>A.</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Peng</surname>
<given-names>J.</given-names>
</string-name> and <string-name>
<surname>Liu</surname>
<given-names>C. W.</given-names>
</string-name> (<year>2014</year>) <article-title>Autoregulation of the 26S proteasome by in situ ubiquitination</article-title>. <source/>Mol. Biol. Cell
<volume>25</volume>, <fpage>1824</fpage>–<lpage>1835</lpage>.<pub-id pub-id-type="pmid">24743594</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0058">
<mixed-citation id="jnc13723-cit-0058" publication-type="journal">
<string-name>
<surname>Jarome</surname>
<given-names>T. J.</given-names>
</string-name> and <string-name>
<surname>Helmstetter</surname>
<given-names>F. J.</given-names>
</string-name> (<year>2014</year>) <article-title>Protein degradation and protein synthesis in long‐term memory formation</article-title>. <source/>Front Mol. Neurosci.
<volume>7</volume>, <fpage>61</fpage>.<pub-id pub-id-type="pmid">25018696</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0059">
<mixed-citation id="jnc13723-cit-0059" publication-type="journal">
<string-name>
<surname>Jeyabalan</surname>
<given-names>N.</given-names>
</string-name> and <string-name>
<surname>Clement</surname>
<given-names>J. P.</given-names>
</string-name> (<year>2016</year>) <article-title>SYNGAP1: mind the Gap</article-title>. <source/>Front Cell Neurosci.
<volume>10</volume>, <fpage>32</fpage>.<pub-id pub-id-type="pmid">26912996</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0060">
<mixed-citation id="jnc13723-cit-0060" publication-type="journal">
<string-name>
<surname>Jiang</surname>
<given-names>Y. H.</given-names>
</string-name>, <string-name>
<surname>Armstrong</surname>
<given-names>D.</given-names>
</string-name>, <string-name>
<surname>Albrecht</surname>
<given-names>U.</given-names>
</string-name>, <string-name>
<surname>Atkins</surname>
<given-names>C. M.</given-names>
</string-name>, <string-name>
<surname>Noebels</surname>
<given-names>J. L.</given-names>
</string-name>, <string-name>
<surname>Eichele</surname>
<given-names>G.</given-names>
</string-name>, <string-name>
<surname>Sweatt</surname>
<given-names>J. D.</given-names>
</string-name> and <string-name>
<surname>Beaudet</surname>
<given-names>A. L.</given-names>
</string-name> (<year>1998</year>) <article-title>Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long‐term potentiation</article-title>. <source/>Neuron
<volume>21</volume>, <fpage>799</fpage>–<lpage>811</lpage>.<pub-id pub-id-type="pmid">9808466</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0061">
<mixed-citation id="jnc13723-cit-0061" publication-type="journal">
<string-name>
<surname>Jurd</surname>
<given-names>R.</given-names>
</string-name>, <string-name>
<surname>Thornton</surname>
<given-names>C.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>J.</given-names>
</string-name>, <string-name>
<surname>Luong</surname>
<given-names>K.</given-names>
</string-name>, <string-name>
<surname>Phamluong</surname>
<given-names>K.</given-names>
</string-name>, <string-name>
<surname>Kharazia</surname>
<given-names>V.</given-names>
</string-name>, <string-name>
<surname>Gibb</surname>
<given-names>S. L.</given-names>
</string-name> and <string-name>
<surname>Ron</surname>
<given-names>D.</given-names>
</string-name> (<year>2008</year>) <article-title>Mind bomb‐2 is an E3 ligase that ubiquitinates the N‐methyl‐D‐aspartate receptor NR2B subunit in a phosphorylation‐dependent manner</article-title>. <source/>J. Biol. Chem.
<volume>283</volume>, <fpage>301</fpage>–<lpage>310</lpage>.<pub-id pub-id-type="pmid">17962190</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0062">
<mixed-citation id="jnc13723-cit-0062" publication-type="journal">
<string-name>
<surname>Karpova</surname>
<given-names>A.</given-names>
</string-name>, <string-name>
<surname>Mikhaylova</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Thomas</surname>
<given-names>U.</given-names>
</string-name>, <string-name>
<surname>Knopfel</surname>
<given-names>T.</given-names>
</string-name> and <string-name>
<surname>Behnisch</surname>
<given-names>T.</given-names>
</string-name> (<year>2006</year>) <article-title>Involvement of protein synthesis and degradation in long‐term potentiation of Schaffer collateral CA1 synapses</article-title>. <source/>J. Neurosci.
<volume>26</volume>, <fpage>4949</fpage>–<lpage>4955</lpage>.<pub-id pub-id-type="pmid">16672670</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0063">
<mixed-citation id="jnc13723-cit-0063" publication-type="journal">
<string-name>
<surname>Kato</surname>
<given-names>A.</given-names>
</string-name>, <string-name>
<surname>Rouach</surname>
<given-names>N.</given-names>
</string-name>, <string-name>
<surname>Nicoll</surname>
<given-names>R. A.</given-names>
</string-name> and <string-name>
<surname>Bredt</surname>
<given-names>D. S.</given-names>
</string-name> (<year>2005</year>) <article-title>Activity‐dependent NMDA receptor degradation mediated by retrotranslocation and ubiquitination</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>102</volume>, <fpage>5600</fpage>–<lpage>5605</lpage>.<pub-id pub-id-type="pmid">15809437</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0064">
<mixed-citation id="jnc13723-cit-0064" publication-type="journal">
<string-name>
<surname>Kelleher</surname>
<given-names>R. J.</given-names>, <suffix>3rd</suffix>
</string-name> and <string-name>
<surname>Bear</surname>
<given-names>M. F.</given-names>
</string-name> (<year>2008</year>) <article-title>The autistic neuron: troubled translation?</article-title>
<source/>Cell
<volume>135</volume>, <fpage>401</fpage>–<lpage>406</lpage>.<pub-id pub-id-type="pmid">18984149</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0065">
<mixed-citation id="jnc13723-cit-0065" publication-type="journal">
<string-name>
<surname>Kelleher</surname>
<given-names>R. J.</given-names>, <suffix>3rd</suffix>
</string-name>, <string-name>
<surname>Geigenmuller</surname>
<given-names>U.</given-names>
</string-name>, <string-name>
<surname>Hovhannisyan</surname>
<given-names>H.</given-names>
</string-name>, <string-name>
<surname>Trautman</surname>
<given-names>E.</given-names>
</string-name>, <string-name>
<surname>Pinard</surname>
<given-names>R.</given-names>
</string-name>, <string-name>
<surname>Rathmell</surname>
<given-names>B.</given-names>
</string-name>, <string-name>
<surname>Carpenter</surname>
<given-names>R.</given-names>
</string-name> and <string-name>
<surname>Margulies</surname>
<given-names>D.</given-names>
</string-name> (<year>2012</year>) <article-title>High‐throughput sequencing of mGluR signaling pathway genes reveals enrichment of rare variants in autism</article-title>. <source/>PLoS ONE
<volume>7</volume>, <fpage>e35003</fpage>.<pub-id pub-id-type="pmid">22558107</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0066">
<mixed-citation id="jnc13723-cit-0066" publication-type="journal">
<string-name>
<surname>Kishino</surname>
<given-names>T.</given-names>
</string-name>, <string-name>
<surname>Lalande</surname>
<given-names>M.</given-names>
</string-name> and <string-name>
<surname>Wagstaff</surname>
<given-names>J.</given-names>
</string-name> (<year>1997</year>) <article-title>UBE3A/E6‐AP mutations cause Angelman syndrome</article-title>. <source/>Nat. Genet.
<volume>15</volume>, <fpage>70</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="pmid">8988171</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0067">
<mixed-citation id="jnc13723-cit-0067" publication-type="journal">
<string-name>
<surname>Klauck</surname>
<given-names>S. M.</given-names>
</string-name>, <string-name>
<surname>Felder</surname>
<given-names>B.</given-names>
</string-name>, <string-name>
<surname>Kolb‐Kokocinski</surname>
<given-names>A.</given-names>
</string-name>
<italic>et al</italic> (<year>2006</year>) <article-title>Mutations in the ribosomal protein gene RPL10 suggest a novel modulating disease mechanism for autism</article-title>. <source/>Mol. Psychiatry
<volume>11</volume>, <fpage>1073</fpage>–<lpage>1084</lpage>.<pub-id pub-id-type="pmid">16940977</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0068">
<mixed-citation id="jnc13723-cit-0068" publication-type="journal">
<string-name>
<surname>Klein</surname>
<given-names>M. E.</given-names>
</string-name>, <string-name>
<surname>Castillo</surname>
<given-names>P. E.</given-names>
</string-name> and <string-name>
<surname>Jordan</surname>
<given-names>B. A.</given-names>
</string-name> (<year>2015</year>) <article-title>Coordination between translation and degradation regulates inducibility of mGluR‐LTD</article-title>. <source/>Cell Rep.
<volume>10</volume>, <fpage>1459</fpage>–<lpage>1466</lpage>.</mixed-citation>
</ref>
<ref id="jnc13723-bib-0069">
<mixed-citation id="jnc13723-cit-0069" publication-type="journal">
<string-name>
<surname>Komiyama</surname>
<given-names>N. H.</given-names>
</string-name>, <string-name>
<surname>Watabe</surname>
<given-names>A. M.</given-names>
</string-name>, <string-name>
<surname>Carlisle</surname>
<given-names>H. J.</given-names>
</string-name>
<italic>et al</italic> (<year>2002</year>) <article-title>SynGAP regulates ERK/MAPK signaling, synaptic plasticity, and learning in the complex with postsynaptic density 95 and NMDA receptor</article-title>. <source/>J. Neurosci.
<volume>22</volume>, <fpage>9721</fpage>–<lpage>9732</lpage>.<pub-id pub-id-type="pmid">12427827</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0070">
<mixed-citation id="jnc13723-cit-0070" publication-type="journal">
<string-name>
<surname>Krab</surname>
<given-names>L. C.</given-names>
</string-name>, <string-name>
<surname>Goorden</surname>
<given-names>S. M.</given-names>
</string-name> and <string-name>
<surname>Elgersma</surname>
<given-names>Y.</given-names>
</string-name> (<year>2008</year>) <article-title>Oncogenes on my mind: ERK and MTOR signaling in cognitive diseases</article-title>. <source/>Trends Genet.
<volume>24</volume>, <fpage>498</fpage>–<lpage>510</lpage>.<pub-id pub-id-type="pmid">18774199</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0071">
<mixed-citation id="jnc13723-cit-0071" publication-type="journal">
<string-name>
<surname>Krumm</surname>
<given-names>N.</given-names>
</string-name>, <string-name>
<surname>Turner</surname>
<given-names>T. N.</given-names>
</string-name>, <string-name>
<surname>Baker</surname>
<given-names>C.</given-names>
</string-name>
<italic>et al</italic> (<year>2015</year>) <article-title>Excess of rare, inherited truncating mutations in autism</article-title>. <source/>Nat. Genet.
<volume>47</volume>, <fpage>582</fpage>–<lpage>588</lpage>.<pub-id pub-id-type="pmid">25961944</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0072">
<mixed-citation id="jnc13723-cit-0072" publication-type="journal">
<string-name>
<surname>Kuhnle</surname>
<given-names>S.</given-names>
</string-name>, <string-name>
<surname>Mothes</surname>
<given-names>B.</given-names>
</string-name>, <string-name>
<surname>Matentzoglu</surname>
<given-names>K.</given-names>
</string-name> and <string-name>
<surname>Scheffner</surname>
<given-names>M.</given-names>
</string-name> (<year>2013</year>) <article-title>Role of the ubiquitin ligase E6AP/UBE3A in controlling levels of the synaptic protein Arc</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>110</volume>, <fpage>8888</fpage>–<lpage>8893</lpage>.<pub-id pub-id-type="pmid">23671107</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0073">
<mixed-citation id="jnc13723-cit-0073" publication-type="journal">
<string-name>
<surname>Kushner</surname>
<given-names>S. A.</given-names>
</string-name>, <string-name>
<surname>Elgersma</surname>
<given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Murphy</surname>
<given-names>G. G.</given-names>
</string-name>
<italic>et al</italic> (<year>2005</year>) <article-title>Modulation of presynaptic plasticity and learning by the H‐ras/extracellular signal‐regulated kinase/synapsin I signaling pathway</article-title>. <source/>J. Neurosci.
<volume>25</volume>, <fpage>9721</fpage>–<lpage>9734</lpage>.<pub-id pub-id-type="pmid">16237176</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0074">
<mixed-citation id="jnc13723-cit-0074" publication-type="journal">
<string-name>
<surname>Kwon</surname>
<given-names>C. H.</given-names>
</string-name>, <string-name>
<surname>Luikart</surname>
<given-names>B. W.</given-names>
</string-name>, <string-name>
<surname>Powell</surname>
<given-names>C. M.</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>J.</given-names>
</string-name>, <string-name>
<surname>Matheny</surname>
<given-names>S. A.</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Baker</surname>
<given-names>S. J.</given-names>
</string-name> and <string-name>
<surname>Parada</surname>
<given-names>L. F.</given-names>
</string-name> (<year>2006</year>) <article-title>Pten regulates neuronal arborization and social interaction in mice</article-title>. <source/>Neuron
<volume>50</volume>, <fpage>377</fpage>–<lpage>388</lpage>.<pub-id pub-id-type="pmid">16675393</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0075">
<mixed-citation id="jnc13723-cit-0075" publication-type="journal">
<string-name>
<surname>LaSalle</surname>
<given-names>J. M.</given-names>
</string-name>, <string-name>
<surname>Reiter</surname>
<given-names>L. T.</given-names>
</string-name> and <string-name>
<surname>Chamberlain</surname>
<given-names>S. J.</given-names>
</string-name> (<year>2015</year>) <article-title>Epigenetic regulation of UBE3A and roles in human neurodevelopmental disorders</article-title>. <source/>Epigenomics
<volume>7</volume>, <fpage>1213</fpage>–<lpage>1228</lpage>.<pub-id pub-id-type="pmid">26585570</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0076">
<mixed-citation id="jnc13723-cit-0076" publication-type="journal">
<string-name>
<surname>Lee</surname>
<given-names>S. H.</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>J. H.</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>N.</given-names>
</string-name>
<italic>et al</italic> (<year>2008</year>) <article-title>Synaptic protein degradation underlies destabilization of retrieved fear memory</article-title>. <source/>Science
<volume>319</volume>, <fpage>1253</fpage>–<lpage>1256</lpage>.<pub-id pub-id-type="pmid">18258863</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0077">
<mixed-citation id="jnc13723-cit-0077" publication-type="journal">
<string-name>
<surname>Lee</surname>
<given-names>P. C.</given-names>
</string-name>, <string-name>
<surname>Dodart</surname>
<given-names>J. C.</given-names>
</string-name>, <string-name>
<surname>Aron</surname>
<given-names>L.</given-names>
</string-name>, <string-name>
<surname>Finley</surname>
<given-names>L. W.</given-names>
</string-name>, <string-name>
<surname>Bronson</surname>
<given-names>R. T.</given-names>
</string-name>, <string-name>
<surname>Haigis</surname>
<given-names>M. C.</given-names>
</string-name>, <string-name>
<surname>Yankner</surname>
<given-names>B. A.</given-names>
</string-name> and <string-name>
<surname>Harper</surname>
<given-names>J. W.</given-names>
</string-name> (<year>2013</year>) <article-title>Altered social behavior and neuronal development in mice lacking the Uba6‐Use1 ubiquitin transfer system</article-title>. <source/>Mol. Cell
<volume>50</volume>, <fpage>172</fpage>–<lpage>184</lpage>.<pub-id pub-id-type="pmid">23499007</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0078">
<mixed-citation id="jnc13723-cit-0078" publication-type="journal">
<string-name>
<surname>Lee</surname>
<given-names>Y. S.</given-names>
</string-name>, <string-name>
<surname>Ehninger</surname>
<given-names>D.</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>M.</given-names>
</string-name>
<italic>et al</italic> (<year>2014</year>) <article-title>Mechanism and treatment for learning and memory deficits in mouse models of Noonan syndrome</article-title>. <source/>Nat. Neurosci.
<volume>17</volume>, <fpage>1736</fpage>–<lpage>1743</lpage>.<pub-id pub-id-type="pmid">25383899</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0079">
<mixed-citation id="jnc13723-cit-0079" publication-type="journal">
<string-name>
<surname>Lee</surname>
<given-names>J. Y.</given-names>
</string-name>, <string-name>
<surname>Kwak</surname>
<given-names>M.</given-names>
</string-name> and <string-name>
<surname>Lee</surname>
<given-names>P. C.</given-names>
</string-name> (<year>2015</year>) <article-title>Impairment of social behavior and communication in mice lacking the Uba6‐dependent ubiquitin activation system</article-title>. <source/>Behav. Brain Res.
<volume>281</volume>, <fpage>78</fpage>–<lpage>85</lpage>.<pub-id pub-id-type="pmid">25523030</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0080">
<mixed-citation id="jnc13723-cit-0080" publication-type="journal">
<string-name>
<surname>Li</surname>
<given-names>Q.</given-names>
</string-name>, <string-name>
<surname>Korte</surname>
<given-names>M.</given-names>
</string-name> and <string-name>
<surname>Sajikumar</surname>
<given-names>S.</given-names>
</string-name> (<year>2015</year>) <article-title>Ubiquitin‐proteasome system inhibition promotes long‐term depression and synaptic tagging/capture</article-title>. <source/>Cereb. Cortex
<volume>26</volume>, <fpage>2541</fpage>–<lpage>2548</lpage>.<pub-id pub-id-type="pmid">25924950</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0081">
<mixed-citation id="jnc13723-cit-0081" publication-type="journal">
<string-name>
<surname>de Ligt</surname>
<given-names>J.</given-names>
</string-name>, <string-name>
<surname>Willemsen</surname>
<given-names>M. H.</given-names>
</string-name>, <string-name>
<surname>van Bon</surname>
<given-names>B. W.</given-names>
</string-name>
<italic>et al</italic> (<year>2012</year>) <article-title>Diagnostic exome sequencing in persons with severe intellectual disability</article-title>. <source/>N. Engl. J. Med.
<volume>367</volume>, <fpage>1921</fpage>–<lpage>1929</lpage>.<pub-id pub-id-type="pmid">23033978</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0082">
<mixed-citation id="jnc13723-cit-0082" publication-type="journal">
<string-name>
<surname>Lin</surname>
<given-names>A. W.</given-names>
</string-name> and <string-name>
<surname>Man</surname>
<given-names>H. Y.</given-names>
</string-name> (<year>2013</year>) <article-title>Ubiquitination of neurotransmitter receptors and postsynaptic scaffolding proteins</article-title>. <source/>Neural. Plast.
<volume>2013</volume>, <fpage>432057</fpage>.<pub-id pub-id-type="pmid">23431475</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0083">
<mixed-citation id="jnc13723-cit-0083" publication-type="journal">
<string-name>
<surname>Lopez‐Salon</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Alonso</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Vianna</surname>
<given-names>M. R.</given-names>
</string-name>, <string-name>
<surname>Viola</surname>
<given-names>H.</given-names>
</string-name>, <string-name>
<surname>Mello e Souza</surname>
<given-names>T.</given-names>
</string-name>, <string-name>
<surname>Izquierdo</surname>
<given-names>I.</given-names>
</string-name>, <string-name>
<surname>Pasquini</surname>
<given-names>J. M.</given-names>
</string-name> and <string-name>
<surname>Medina</surname>
<given-names>J. H.</given-names>
</string-name> (<year>2001</year>) <article-title>The ubiquitin‐proteasome cascade is required for mammalian long‐term memory formation</article-title>. <source/>Eur. J. Neurosci.
<volume>14</volume>, <fpage>1820</fpage>–<lpage>1826</lpage>.<pub-id pub-id-type="pmid">11860477</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0084">
<mixed-citation id="jnc13723-cit-0084" publication-type="journal">
<string-name>
<surname>Mabb</surname>
<given-names>A. M.</given-names>
</string-name>, <string-name>
<surname>Judson</surname>
<given-names>M. C.</given-names>
</string-name>, <string-name>
<surname>Zylka</surname>
<given-names>M. J.</given-names>
</string-name> and <string-name>
<surname>Philpot</surname>
<given-names>B. D.</given-names>
</string-name> (<year>2011</year>) <article-title>Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes</article-title>. <source/>Trends Neurosci.
<volume>34</volume>, <fpage>293</fpage>–<lpage>303</lpage>.<pub-id pub-id-type="pmid">21592595</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0085">
<mixed-citation id="jnc13723-cit-0085" publication-type="journal">
<string-name>
<surname>Mabb</surname>
<given-names>A. M.</given-names>
</string-name>, <string-name>
<surname>Je</surname>
<given-names>H. S.</given-names>
</string-name>, <string-name>
<surname>Wall</surname>
<given-names>M. J.</given-names>
</string-name>, <string-name>
<surname>Robinson</surname>
<given-names>C. G.</given-names>
</string-name>, <string-name>
<surname>Larsen</surname>
<given-names>R. S.</given-names>
</string-name>, <string-name>
<surname>Qiang</surname>
<given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Correa</surname>
<given-names>S. A.</given-names>
</string-name> and <string-name>
<surname>Ehlers</surname>
<given-names>M. D.</given-names>
</string-name> (<year>2014</year>) <article-title>Triad3A regulates synaptic strength by ubiquitination of Arc</article-title>. <source/>Neuron
<volume>82</volume>, <fpage>1299</fpage>–<lpage>1316</lpage>.<pub-id pub-id-type="pmid">24945773</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0086">
<mixed-citation id="jnc13723-cit-0086" publication-type="journal">
<string-name>
<surname>Manabe</surname>
<given-names>T.</given-names>
</string-name>, <string-name>
<surname>Aiba</surname>
<given-names>A.</given-names>
</string-name>, <string-name>
<surname>Yamada</surname>
<given-names>A.</given-names>
</string-name>, <string-name>
<surname>Ichise</surname>
<given-names>T.</given-names>
</string-name>, <string-name>
<surname>Sakagami</surname>
<given-names>H.</given-names>
</string-name>, <string-name>
<surname>Kondo</surname>
<given-names>H.</given-names>
</string-name> and <string-name>
<surname>Katsuki</surname>
<given-names>M.</given-names>
</string-name> (<year>2000</year>) <article-title>Regulation of long‐term potentiation by H‐Ras through NMDA receptor phosphorylation</article-title>. <source/>J. Neurosci.
<volume>20</volume>, <fpage>2504</fpage>–<lpage>2511</lpage>.<pub-id pub-id-type="pmid">10729330</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0087">
<mixed-citation id="jnc13723-cit-0087" publication-type="journal">
<string-name>
<surname>Mandel‐Brehm</surname>
<given-names>C.</given-names>
</string-name>, <string-name>
<surname>Salogiannis</surname>
<given-names>J.</given-names>
</string-name>, <string-name>
<surname>Dhamne</surname>
<given-names>S. C.</given-names>
</string-name>, <string-name>
<surname>Rotenberg</surname>
<given-names>A.</given-names>
</string-name> and <string-name>
<surname>Greenberg</surname>
<given-names>M. E.</given-names>
</string-name> (<year>2015</year>) <article-title>Seizure‐like activity in a juvenile Angelman syndrome mouse model is attenuated by reducing Arc expression</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>112</volume>, <fpage>5129</fpage>–<lpage>5134</lpage>.<pub-id pub-id-type="pmid">25848016</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0088">
<mixed-citation id="jnc13723-cit-0088" publication-type="journal">
<string-name>
<surname>Marshall</surname>
<given-names>C. R.</given-names>
</string-name>, <string-name>
<surname>Noor</surname>
<given-names>A.</given-names>
</string-name>, <string-name>
<surname>Vincent</surname>
<given-names>J. B.</given-names>
</string-name>
<italic>et al</italic> (<year>2008</year>) <article-title>Structural variation of chromosomes in autism spectrum disorder</article-title>. <source/>Am. J. Hum. Genet.
<volume>82</volume>, <fpage>477</fpage>–<lpage>488</lpage>.<pub-id pub-id-type="pmid">18252227</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0089">
<mixed-citation id="jnc13723-cit-0089" publication-type="journal">
<string-name>
<surname>Matsumoto</surname>
<given-names>A.</given-names>
</string-name>, <string-name>
<surname>Kuwajima</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Miyake</surname>
<given-names>K.</given-names>
</string-name>, <string-name>
<surname>Kojima</surname>
<given-names>K.</given-names>
</string-name>, <string-name>
<surname>Nakashima</surname>
<given-names>N.</given-names>
</string-name>, <string-name>
<surname>Jimbo</surname>
<given-names>E. F.</given-names>
</string-name>, <string-name>
<surname>Kubota</surname>
<given-names>T.</given-names>
</string-name>, <string-name>
<surname>Momoi</surname>
<given-names>M. Y.</given-names>
</string-name> and <string-name>
<surname>Yamagata</surname>
<given-names>T.</given-names>
</string-name> (<year>2013</year>) <article-title>An Xp22.12 microduplication including RPS6KA3 identified in a family with variably affected intellectual and behavioral disabilities</article-title>. <source/>J. Hum. Genet.
<volume>58</volume>, <fpage>755</fpage>–<lpage>757</lpage>.<pub-id pub-id-type="pmid">23985797</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0090">
<mixed-citation id="jnc13723-cit-0090" publication-type="journal">
<string-name>
<surname>Matsuura</surname>
<given-names>T.</given-names>
</string-name>, <string-name>
<surname>Sutcliffe</surname>
<given-names>J. S.</given-names>
</string-name>, <string-name>
<surname>Fang</surname>
<given-names>P.</given-names>
</string-name>, <string-name>
<surname>Galjaard</surname>
<given-names>R. J.</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>Y. H.</given-names>
</string-name>, <string-name>
<surname>Benton</surname>
<given-names>C. S.</given-names>
</string-name>, <string-name>
<surname>Rommens</surname>
<given-names>J. M.</given-names>
</string-name> and <string-name>
<surname>Beaudet</surname>
<given-names>A. L.</given-names>
</string-name> (<year>1997</year>) <article-title>De novo truncating mutations in E6‐AP ubiquitin‐protein ligase gene (UBE3A) in Angelman syndrome</article-title>. <source/>Nat. Genet.
<volume>15</volume>, <fpage>74</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="pmid">8988172</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0091">
<mixed-citation id="jnc13723-cit-0091" publication-type="journal">
<string-name>
<surname>Moriyoshi</surname>
<given-names>K.</given-names>
</string-name>, <string-name>
<surname>Iijima</surname>
<given-names>K.</given-names>
</string-name>, <string-name>
<surname>Fujii</surname>
<given-names>H.</given-names>
</string-name>, <string-name>
<surname>Ito</surname>
<given-names>H.</given-names>
</string-name>, <string-name>
<surname>Cho</surname>
<given-names>Y.</given-names>
</string-name> and <string-name>
<surname>Nakanishi</surname>
<given-names>S.</given-names>
</string-name> (<year>2004</year>) <article-title>Seven in absentia homolog 1A mediates ubiquitination and degradation of group 1 metabotropic glutamate receptors</article-title>. <source/>Proc. Natl Acad. Sci. USA
<volume>101</volume>, <fpage>8614</fpage>–<lpage>8619</lpage>.<pub-id pub-id-type="pmid">15163799</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0092">
<mixed-citation id="jnc13723-cit-0092" publication-type="journal">
<string-name>
<surname>Na</surname>
<given-names>C. H.</given-names>
</string-name>, <string-name>
<surname>Jones</surname>
<given-names>D. R.</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>X.</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>Y.</given-names>
</string-name> and <string-name>
<surname>Peng</surname>
<given-names>J.</given-names>
</string-name> (<year>2012</year>) <article-title>Synaptic protein ubiquitination in rat brain revealed by antibody‐based ubiquitome analysis</article-title>. <source/>J. Proteome Res.
<volume>11</volume>, <fpage>4722</fpage>–<lpage>4732</lpage>.<pub-id pub-id-type="pmid">22871113</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0093">
<mixed-citation id="jnc13723-cit-0093" publication-type="journal">
<string-name>
<surname>Najmabadi</surname>
<given-names>H.</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>H.</given-names>
</string-name>, <string-name>
<surname>Garshasbi</surname>
<given-names>M.</given-names>
</string-name>
<italic>et al</italic> (<year>2011</year>) <article-title>Deep sequencing reveals 50 novel genes for recessive cognitive disorders</article-title>. <source/>Nature
<volume>478</volume>, <fpage>57</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="pmid">21937992</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0094">
<mixed-citation id="jnc13723-cit-0094" publication-type="journal">
<string-name>
<surname>Nakajima</surname>
<given-names>J.</given-names>
</string-name>, <string-name>
<surname>Okamoto</surname>
<given-names>N.</given-names>
</string-name>, <string-name>
<surname>Tohyama</surname>
<given-names>J.</given-names>
</string-name>
<italic>et al</italic> (<year>2015</year>) <article-title>De novo EEF1A2 mutations in patients with characteristic facial features, intellectual disability, autistic behaviors and epilepsy</article-title>. <source/>Clin. Genet.
<volume>87</volume>, <fpage>356</fpage>–<lpage>361</lpage>.<pub-id pub-id-type="pmid">24697219</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0095">
<mixed-citation id="jnc13723-cit-0095" publication-type="journal">
<string-name>
<surname>Nava</surname>
<given-names>C.</given-names>
</string-name>, <string-name>
<surname>Lamari</surname>
<given-names>F.</given-names>
</string-name>, <string-name>
<surname>Heron</surname>
<given-names>D.</given-names>
</string-name>
<italic>et al</italic> (<year>2012</year>) <article-title>Analysis of the chromosome X exome in patients with autism spectrum disorders identified novel candidate genes, including TMLHE</article-title>. <source/>Transl. Psychiatry
<volume>2</volume>, <fpage>e179</fpage>.<pub-id pub-id-type="pmid">23092983</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0096">
<mixed-citation id="jnc13723-cit-0096" publication-type="journal">
<string-name>
<surname>Neves‐Pereira</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Muller</surname>
<given-names>B.</given-names>
</string-name>, <string-name>
<surname>Massie</surname>
<given-names>D.</given-names>
</string-name>, <string-name>
<surname>Williams</surname>
<given-names>J. H.</given-names>
</string-name>, <string-name>
<surname>O'Brien</surname>
<given-names>P. C.</given-names>
</string-name>, <string-name>
<surname>Hughes</surname>
<given-names>A.</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>S. B.</given-names>
</string-name>, <string-name>
<surname>Clair</surname>
<given-names>D. S.</given-names>
</string-name> and <string-name>
<surname>Miedzybrodzka</surname>
<given-names>Z.</given-names>
</string-name> (<year>2009</year>) <article-title>Deregulation of EIF4E: a novel mechanism for autism</article-title>. <source/>J. Med. Genet.
<volume>46</volume>, <fpage>759</fpage>–<lpage>765</lpage>.<pub-id pub-id-type="pmid">19556253</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0097">
<mixed-citation id="jnc13723-cit-0097" publication-type="journal">
<string-name>
<surname>Nishimura</surname>
<given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Martin</surname>
<given-names>C. L.</given-names>
</string-name>, <string-name>
<surname>Vazquez‐Lopez</surname>
<given-names>A.</given-names>
</string-name>
<italic>et al</italic> (<year>2007</year>) <article-title>Genome‐wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways</article-title>. <source/>Hum. Mol. Genet.
<volume>16</volume>, <fpage>1682</fpage>–<lpage>1698</lpage>.<pub-id pub-id-type="pmid">17519220</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0098">
<mixed-citation id="jnc13723-cit-0098" publication-type="journal">
<string-name>
<surname>O'Roak</surname>
<given-names>B. J.</given-names>
</string-name>, <string-name>
<surname>Deriziotis</surname>
<given-names>P.</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>C.</given-names>
</string-name>
<italic>et al</italic> (<year>2011</year>) <article-title>Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations</article-title>. <source/>Nat. Genet.
<volume>43</volume>, <fpage>585</fpage>–<lpage>589</lpage>.<pub-id pub-id-type="pmid">21572417</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0099">
<mixed-citation id="jnc13723-cit-0099" publication-type="journal">
<string-name>
<surname>O'Roak</surname>
<given-names>B. J.</given-names>
</string-name>, <string-name>
<surname>Vives</surname>
<given-names>L.</given-names>
</string-name>, <string-name>
<surname>Girirajan</surname>
<given-names>S.</given-names>
</string-name>
<italic>et al</italic> (<year>2012</year>) <article-title>Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations</article-title>. <source/>Nature
<volume>485</volume>, <fpage>246</fpage>–<lpage>250</lpage>.<pub-id pub-id-type="pmid">22495309</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0100">
<mixed-citation id="jnc13723-cit-0100" publication-type="journal">
<string-name>
<surname>Osterweil</surname>
<given-names>E. K.</given-names>
</string-name>, <string-name>
<surname>Krueger</surname>
<given-names>D. D.</given-names>
</string-name>, <string-name>
<surname>Reinhold</surname>
<given-names>K.</given-names>
</string-name> and <string-name>
<surname>Bear</surname>
<given-names>M. F.</given-names>
</string-name> (<year>2010</year>) <article-title>Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome</article-title>. <source/>J. Neurosci.
<volume>30</volume>, <fpage>15616</fpage>–<lpage>15627</lpage>.<pub-id pub-id-type="pmid">21084617</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0101">
<mixed-citation id="jnc13723-cit-0101" publication-type="journal">
<string-name>
<surname>Pak</surname>
<given-names>D. T.</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>S.</given-names>
</string-name>, <string-name>
<surname>Rudolph‐Correia</surname>
<given-names>S.</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>E.</given-names>
</string-name> and <string-name>
<surname>Sheng</surname>
<given-names>M.</given-names>
</string-name> (<year>2001</year>) <article-title>Regulation of dendritic spine morphology by SPAR, a PSD‐95‐associated RapGAP</article-title>. <source/>Neuron
<volume>31</volume>, <fpage>289</fpage>–<lpage>303</lpage>.<pub-id pub-id-type="pmid">11502259</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0102">
<mixed-citation id="jnc13723-cit-0102" publication-type="journal">
<string-name>
<surname>Patrick</surname>
<given-names>G. N.</given-names>
</string-name>, <string-name>
<surname>Bingol</surname>
<given-names>B.</given-names>
</string-name>, <string-name>
<surname>Weld</surname>
<given-names>H. A.</given-names>
</string-name> and <string-name>
<surname>Schuman</surname>
<given-names>E. M.</given-names>
</string-name> (<year>2003</year>) <article-title>Ubiquitin‐mediated proteasome activity is required for agonist‐induced endocytosis of GluRs</article-title>. <source/>Curr. Biol.
<volume>13</volume>, <fpage>2073</fpage>–<lpage>2081</lpage>.<pub-id pub-id-type="pmid">14653997</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0103">
<mixed-citation id="jnc13723-cit-0103" publication-type="journal">
<string-name>
<surname>Pavlopoulos</surname>
<given-names>E.</given-names>
</string-name>, <string-name>
<surname>Trifilieff</surname>
<given-names>P.</given-names>
</string-name>, <string-name>
<surname>Chevaleyre</surname>
<given-names>V.</given-names>
</string-name>, <string-name>
<surname>Fioriti</surname>
<given-names>L.</given-names>
</string-name>, <string-name>
<surname>Zairis</surname>
<given-names>S.</given-names>
</string-name>, <string-name>
<surname>Pagano</surname>
<given-names>A.</given-names>
</string-name>, <string-name>
<surname>Malleret</surname>
<given-names>G.</given-names>
</string-name> and <string-name>
<surname>Kandel</surname>
<given-names>E. R.</given-names>
</string-name> (<year>2011</year>) <article-title>Neuralized1 activates CPEB3: a function for nonproteolytic ubiquitin in synaptic plasticity and memory storage</article-title>. <source/>Cell
<volume>147</volume>, <fpage>1369</fpage>–<lpage>1383</lpage>.<pub-id pub-id-type="pmid">22153079</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0104">
<mixed-citation id="jnc13723-cit-0104" publication-type="journal">
<string-name>
<surname>Pignatelli</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Piccinin</surname>
<given-names>S.</given-names>
</string-name>, <string-name>
<surname>Molinaro</surname>
<given-names>G.</given-names>
</string-name>
<italic>et al</italic> (<year>2014</year>) <article-title>Changes in mGlu5 receptor‐dependent synaptic plasticity and coupling to homer proteins in the hippocampus of Ube3A hemizygous mice modeling angelman syndrome</article-title>. <source/>J. Neurosci.
<volume>34</volume>, <fpage>4558</fpage>–<lpage>4566</lpage>.<pub-id pub-id-type="pmid">24672001</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0105">
<mixed-citation id="jnc13723-cit-0105" publication-type="journal">
<string-name>
<surname>Piton</surname>
<given-names>A.</given-names>
</string-name>, <string-name>
<surname>Gauthier</surname>
<given-names>J.</given-names>
</string-name>, <string-name>
<surname>Hamdan</surname>
<given-names>F. F.</given-names>
</string-name>
<italic>et al</italic> (<year>2011</year>) <article-title>Systematic resequencing of X‐chromosome synaptic genes in autism spectrum disorder and schizophrenia</article-title>. <source/>Mol. Psychiatry
<volume>16</volume>, <fpage>867</fpage>–<lpage>880</lpage>.<pub-id pub-id-type="pmid">20479760</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0106">
<mixed-citation id="jnc13723-cit-0106" publication-type="journal">
<string-name>
<surname>Puffenberger</surname>
<given-names>E. G.</given-names>
</string-name>, <string-name>
<surname>Jinks</surname>
<given-names>R. N.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>H.</given-names>
</string-name>
<italic>et al</italic> (<year>2012</year>) <article-title>A homozygous missense mutation in HERC2 associated with global developmental delay and autism spectrum disorder</article-title>. <source/>Hum. Mutat.
<volume>33</volume>, <fpage>1639</fpage>–<lpage>1646</lpage>.<pub-id pub-id-type="pmid">23065719</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0107">
<mixed-citation id="jnc13723-cit-0107" publication-type="journal">
<string-name>
<surname>Rezvani</surname>
<given-names>K.</given-names>
</string-name>, <string-name>
<surname>Baalman</surname>
<given-names>K.</given-names>
</string-name>, <string-name>
<surname>Teng</surname>
<given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Mee</surname>
<given-names>M. P.</given-names>
</string-name>, <string-name>
<surname>Dawson</surname>
<given-names>S. P.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>H.</given-names>
</string-name>, <string-name>
<surname>De Biasi</surname>
<given-names>M.</given-names>
</string-name> and <string-name>
<surname>Mayer</surname>
<given-names>R. J.</given-names>
</string-name> (<year>2012</year>) <article-title>Proteasomal degradation of the metabotropic glutamate receptor 1alpha is mediated by Homer‐3 via the proteasomal S8 ATPase: signal transduction and synaptic transmission</article-title>. <source/>J. Neurochem.
<volume>122</volume>, <fpage>24</fpage>–<lpage>37</lpage>.<pub-id pub-id-type="pmid">22486777</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0108">
<mixed-citation id="jnc13723-cit-0108" publication-type="journal">
<string-name>
<surname>Roberts</surname>
<given-names>A. E.</given-names>
</string-name>, <string-name>
<surname>Araki</surname>
<given-names>T.</given-names>
</string-name>, <string-name>
<surname>Swanson</surname>
<given-names>K. D.</given-names>
</string-name>
<italic>et al</italic> (<year>2007</year>) <article-title>Germline gain‐of‐function mutations in SOS1 cause Noonan syndrome</article-title>. <source/>Nat. Genet.
<volume>39</volume>, <fpage>70</fpage>–<lpage>74</lpage>.<pub-id pub-id-type="pmid">17143285</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0109">
<mixed-citation id="jnc13723-cit-0109" publication-type="journal">
<string-name>
<surname>Salyakina</surname>
<given-names>D.</given-names>
</string-name>, <string-name>
<surname>Cukier</surname>
<given-names>H. N.</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>J. M.</given-names>
</string-name>
<italic>et al</italic> (<year>2011</year>) <article-title>Copy number variants in extended autism spectrum disorder families reveal candidates potentially involved in autism risk</article-title>. <source/>PLoS ONE
<volume>6</volume>, <fpage>e26049</fpage>.<pub-id pub-id-type="pmid">22016809</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0110">
<mixed-citation id="jnc13723-cit-0110" publication-type="journal">
<string-name>
<surname>Sanders</surname>
<given-names>S. J.</given-names>
</string-name>, <string-name>
<surname>Ercan‐Sencicek</surname>
<given-names>A. G.</given-names>
</string-name>, <string-name>
<surname>Hus</surname>
<given-names>V.</given-names>
</string-name>
<italic>et al</italic> (<year>2011</year>) <article-title>Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism</article-title>. <source/>Neuron
<volume>70</volume>, <fpage>863</fpage>–<lpage>885</lpage>.<pub-id pub-id-type="pmid">21658581</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0111">
<mixed-citation id="jnc13723-cit-0111" publication-type="journal">
<string-name>
<surname>Santini</surname>
<given-names>E.</given-names>
</string-name>, <string-name>
<surname>Huynh</surname>
<given-names>T. N.</given-names>
</string-name>, <string-name>
<surname>MacAskill</surname>
<given-names>A. F.</given-names>
</string-name>, <string-name>
<surname>Carter</surname>
<given-names>A. G.</given-names>
</string-name>, <string-name>
<surname>Pierre</surname>
<given-names>P.</given-names>
</string-name>, <string-name>
<surname>Ruggero</surname>
<given-names>D.</given-names>
</string-name>, <string-name>
<surname>Kaphzan</surname>
<given-names>H.</given-names>
</string-name> and <string-name>
<surname>Klann</surname>
<given-names>E.</given-names>
</string-name> (<year>2013</year>) <article-title>Exaggerated translation causes synaptic and behavioural aberrations associated with autism</article-title>. <source/>Nature
<volume>493</volume>, <fpage>411</fpage>–<lpage>415</lpage>.<pub-id pub-id-type="pmid">23263185</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0112">
<mixed-citation id="jnc13723-cit-0112" publication-type="journal">
<string-name>
<surname>Santos</surname>
<given-names>A. R.</given-names>
</string-name>, <string-name>
<surname>Mele</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Vaz</surname>
<given-names>S. H.</given-names>
</string-name>
<italic>et al</italic> (<year>2015</year>) <article-title>Differential role of the proteasome in the early and late phases of BDNF‐induced facilitation of LTP</article-title>. <source/>J. Neurosci.
<volume>35</volume>, <fpage>3319</fpage>–<lpage>3329</lpage>.<pub-id pub-id-type="pmid">25716833</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0113">
<mixed-citation id="jnc13723-cit-0113" publication-type="journal">
<string-name>
<surname>Schmidt</surname>
<given-names>M.</given-names>
</string-name> and <string-name>
<surname>Finley</surname>
<given-names>D.</given-names>
</string-name> (<year>2014</year>) <article-title>Regulation of proteasome activity in health and disease</article-title>. <source/>Biochim. Biophys. Acta
<volume>1843</volume>, <fpage>13</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="pmid">23994620</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0114">
<mixed-citation id="jnc13723-cit-0114" publication-type="journal">
<string-name>
<surname>Schwarz</surname>
<given-names>L. A.</given-names>
</string-name>, <string-name>
<surname>Hall</surname>
<given-names>B. J.</given-names>
</string-name> and <string-name>
<surname>Patrick</surname>
<given-names>G. N.</given-names>
</string-name> (<year>2010</year>) <article-title>Activity‐dependent ubiquitination of GluA1 mediates a distinct AMPA receptor endocytosis and sorting pathway</article-title>. <source/>J. Neurosci.
<volume>30</volume>, <fpage>16718</fpage>–<lpage>16729</lpage>.<pub-id pub-id-type="pmid">21148011</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0115">
<mixed-citation id="jnc13723-cit-0115" publication-type="journal">
<string-name>
<surname>Scudder</surname>
<given-names>S. L.</given-names>
</string-name>, <string-name>
<surname>Goo</surname>
<given-names>M. S.</given-names>
</string-name>, <string-name>
<surname>Cartier</surname>
<given-names>A. E.</given-names>
</string-name>, <string-name>
<surname>Molteni</surname>
<given-names>A.</given-names>
</string-name>, <string-name>
<surname>Schwarz</surname>
<given-names>L. A.</given-names>
</string-name>, <string-name>
<surname>Wright</surname>
<given-names>R.</given-names>
</string-name> and <string-name>
<surname>Patrick</surname>
<given-names>G. N.</given-names>
</string-name> (<year>2014</year>) <article-title>Synaptic strength is bidirectionally controlled by opposing activity‐dependent regulation of Nedd4‐1 and USP8</article-title>. <source/>J. Neurosci.
<volume>34</volume>, <fpage>16637</fpage>–<lpage>16649</lpage>.<pub-id pub-id-type="pmid">25505317</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0116">
<mixed-citation id="jnc13723-cit-0116" publication-type="journal">
<string-name>
<surname>Silva</surname>
<given-names>A. J.</given-names>
</string-name>, <string-name>
<surname>Frankland</surname>
<given-names>P. W.</given-names>
</string-name>, <string-name>
<surname>Marowitz</surname>
<given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Friedman</surname>
<given-names>E.</given-names>
</string-name>, <string-name>
<surname>Laszlo</surname>
<given-names>G. S.</given-names>
</string-name>, <string-name>
<surname>Cioffi</surname>
<given-names>D.</given-names>
</string-name>, <string-name>
<surname>Jacks</surname>
<given-names>T.</given-names>
</string-name> and <string-name>
<surname>Bourtchuladze</surname>
<given-names>R.</given-names>
</string-name> (<year>1997</year>) <article-title>A mouse model for the learning and memory deficits associated with neurofibromatosis type I</article-title>. <source/>Nat. Genet.
<volume>15</volume>, <fpage>281</fpage>–<lpage>284</lpage>.<pub-id pub-id-type="pmid">9054942</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0117">
<mixed-citation id="jnc13723-cit-0117" publication-type="journal">
<string-name>
<surname>Smith</surname>
<given-names>S. E.</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>Y. D.</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>G.</given-names>
</string-name>, <string-name>
<surname>Jin</surname>
<given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Stoppel</surname>
<given-names>D. C.</given-names>
</string-name> and <string-name>
<surname>Anderson</surname>
<given-names>M. P.</given-names>
</string-name> (<year>2011</year>) <article-title>Increased gene dosage of Ube3a results in autism traits and decreased glutamate synaptic transmission in mice</article-title>. <source/>Sci. Transl. Med., <volume>3</volume>, <fpage>103ra97</fpage>.</mixed-citation>
</ref>
<ref id="jnc13723-bib-0118">
<mixed-citation id="jnc13723-cit-0118" publication-type="journal">
<string-name>
<surname>Sperow</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Berry</surname>
<given-names>R. B.</given-names>
</string-name>, <string-name>
<surname>Bayazitov</surname>
<given-names>I. T.</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>G.</given-names>
</string-name>, <string-name>
<surname>Baker</surname>
<given-names>S. J.</given-names>
</string-name> and <string-name>
<surname>Zakharenko</surname>
<given-names>S. S.</given-names>
</string-name> (<year>2012</year>) <article-title>Phosphatase and tensin homologue (PTEN) regulates synaptic plasticity independently of its effect on neuronal morphology and migration</article-title>. <source/>J. Physiol.
<volume>590</volume>, <fpage>777</fpage>–<lpage>792</lpage>.<pub-id pub-id-type="pmid">22147265</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0119">
<mixed-citation id="jnc13723-cit-0119" publication-type="journal">
<string-name>
<surname>Sun</surname>
<given-names>J.</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Moreno</surname>
<given-names>S.</given-names>
</string-name>, <string-name>
<surname>Baudry</surname>
<given-names>M.</given-names>
</string-name> and <string-name>
<surname>Bi</surname>
<given-names>X.</given-names>
</string-name> (<year>2015</year>) <article-title>Imbalanced mechanistic target of rapamycin C1 and C2 activity in the cerebellum of Angelman syndrome mice impairs motor function</article-title>. <source/>J. Neurosci.
<volume>35</volume>, <fpage>4706</fpage>–<lpage>4718</lpage>.<pub-id pub-id-type="pmid">25788687</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0120">
<mixed-citation id="jnc13723-cit-0120" publication-type="journal">
<string-name>
<surname>Suryadinata</surname>
<given-names>R.</given-names>
</string-name>, <string-name>
<surname>Roesley</surname>
<given-names>S. N.</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>G.</given-names>
</string-name> and <string-name>
<surname>Sarcevic</surname>
<given-names>B.</given-names>
</string-name> (<year>2014</year>) <article-title>Mechanisms of generating polyubiquitin chains of different topology</article-title>. <source/>Cells
<volume>3</volume>, <fpage>674</fpage>–<lpage>689</lpage>.<pub-id pub-id-type="pmid">24987835</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0121">
<mixed-citation id="jnc13723-cit-0121" publication-type="journal">
<string-name>
<surname>Tai</surname>
<given-names>H. C.</given-names>
</string-name>, <string-name>
<surname>Besche</surname>
<given-names>H.</given-names>
</string-name>, <string-name>
<surname>Goldberg</surname>
<given-names>A. L.</given-names>
</string-name> and <string-name>
<surname>Schuman</surname>
<given-names>E. M.</given-names>
</string-name> (<year>2010</year>) <article-title>Characterization of the Brain 26S Proteasome and its Interacting Proteins</article-title>. <source/>Front Mol. Neurosci.
<volume>3</volume>, <fpage>1</fpage>–<lpage>19</lpage>.<pub-id pub-id-type="pmid">20162032</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0122">
<mixed-citation id="jnc13723-cit-0122" publication-type="journal">
<string-name>
<surname>Tartaglia</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Mehler</surname>
<given-names>E. L.</given-names>
</string-name>, <string-name>
<surname>Goldberg</surname>
<given-names>R.</given-names>
</string-name>
<italic>et al</italic> (<year>2001</year>) <article-title>Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP‐2, cause Noonan syndrome</article-title>. <source/>Nat. Genet.
<volume>29</volume>, <fpage>465</fpage>–<lpage>468</lpage>.<pub-id pub-id-type="pmid">11704759</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0123">
<mixed-citation id="jnc13723-cit-0123" publication-type="journal">
<string-name>
<surname>Tartaglia</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Pennacchio</surname>
<given-names>L. A.</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>C.</given-names>
</string-name>
<italic>et al</italic> (<year>2007</year>) <article-title>Gain‐of‐function SOS1 mutations cause a distinctive form of Noonan syndrome</article-title>. <source/>Nat. Genet.
<volume>39</volume>, <fpage>75</fpage>–<lpage>79</lpage>.<pub-id pub-id-type="pmid">17143282</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0124">
<mixed-citation id="jnc13723-cit-0124" publication-type="journal">
<string-name>
<surname>Thevenon</surname>
<given-names>J.</given-names>
</string-name>, <string-name>
<surname>Michot</surname>
<given-names>C.</given-names>
</string-name>, <string-name>
<surname>Bole</surname>
<given-names>C.</given-names>
</string-name>
<italic>et al</italic> (<year>2015</year>) <article-title>RPL10 mutation segregating in a family with X‐linked syndromic Intellectual Disability</article-title>. <source/>Am. J. Med. Genet. A
<volume>167A</volume>, <fpage>1908</fpage>–<lpage>1912</lpage>.<pub-id pub-id-type="pmid">25846674</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0125">
<mixed-citation id="jnc13723-cit-0125" publication-type="journal">
<string-name>
<surname>Vandewalle</surname>
<given-names>J.</given-names>
</string-name>, <string-name>
<surname>Langen</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Zschatzsch</surname>
<given-names>M.</given-names>
</string-name>
<italic>et al</italic> (<year>2013</year>) <article-title>Ubiquitin ligase HUWE1 regulates axon branching through the Wnt/beta‐catenin pathway in a Drosophila model for intellectual disability</article-title>. <source/>PLoS ONE
<volume>8</volume>, <fpage>e81791</fpage>.<pub-id pub-id-type="pmid">24303071</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0126">
<mixed-citation id="jnc13723-cit-0126" publication-type="journal">
<string-name>
<surname>Wang</surname>
<given-names>J.</given-names>
</string-name>, <string-name>
<surname>Tao</surname>
<given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>F.</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Ott</surname>
<given-names>J.</given-names>
</string-name> and <string-name>
<surname>Saffen</surname>
<given-names>D.</given-names>
</string-name> (<year>2015</year>) <article-title>Common regulatory variants of CYFIP1 contribute to susceptibility for autism spectrum disorder (ASD) and classical autism</article-title>. <source/>Ann. Hum. Genet.
<volume>79</volume>, <fpage>329</fpage>–<lpage>340</lpage>.</mixed-citation>
</ref>
<ref id="jnc13723-bib-0127">
<mixed-citation id="jnc13723-cit-0127" publication-type="journal">
<string-name>
<surname>Weissman</surname>
<given-names>A. M.</given-names>
</string-name> (<year>2001</year>) <article-title>Themes and variations on ubiquitylation</article-title>. <source/>Nat. Rev. Mol. Cell Biol.
<volume>2</volume>, <fpage>169</fpage>–<lpage>178</lpage>.<pub-id pub-id-type="pmid">11265246</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0128">
<mixed-citation id="jnc13723-cit-0128" publication-type="journal">
<string-name>
<surname>Widagdo</surname>
<given-names>J.</given-names>
</string-name>, <string-name>
<surname>Chai</surname>
<given-names>Y. J.</given-names>
</string-name>, <string-name>
<surname>Ridder</surname>
<given-names>M. C.</given-names>
</string-name>, <string-name>
<surname>Chau</surname>
<given-names>Y. Q.</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>
<given-names>R. C.</given-names>
</string-name>, <string-name>
<surname>Sah</surname>
<given-names>P.</given-names>
</string-name>, <string-name>
<surname>Huganir</surname>
<given-names>R. L.</given-names>
</string-name> and <string-name>
<surname>Anggono</surname>
<given-names>V.</given-names>
</string-name> (<year>2015</year>) <article-title>Activity‐dependent ubiquitination of GluA1 and GluA2 regulates AMPA receptor intracellular sorting and degradation</article-title>. <source/>Cell Rep.
<volume>10</volume>, <fpage>783</fpage>–<lpage>795</lpage>.</mixed-citation>
</ref>
<ref id="jnc13723-bib-0129">
<mixed-citation id="jnc13723-cit-0129" publication-type="journal">
<string-name>
<surname>Yi</surname>
<given-names>J. J.</given-names>
</string-name>, <string-name>
<surname>Berrios</surname>
<given-names>J.</given-names>
</string-name>, <string-name>
<surname>Newbern</surname>
<given-names>J. M.</given-names>
</string-name>, <string-name>
<surname>Snider</surname>
<given-names>W. D.</given-names>
</string-name>, <string-name>
<surname>Philpot</surname>
<given-names>B. D.</given-names>
</string-name>, <string-name>
<surname>Hahn</surname>
<given-names>K. M.</given-names>
</string-name> and <string-name>
<surname>Zylka</surname>
<given-names>M. J.</given-names>
</string-name> (<year>2015</year>) <article-title>An autism‐linked mutation disables phosphorylation control of UBE3A</article-title>. <source/>Cell
<volume>162</volume>, <fpage>795</fpage>–<lpage>807</lpage>.<pub-id pub-id-type="pmid">26255772</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0130">
<mixed-citation id="jnc13723-cit-0130" publication-type="journal">
<string-name>
<surname>Zeniou</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Pannetier</surname>
<given-names>S.</given-names>
</string-name>, <string-name>
<surname>Fryns</surname>
<given-names>J. P.</given-names>
</string-name> and <string-name>
<surname>Hanauer</surname>
<given-names>A.</given-names>
</string-name> (<year>2002</year>) <article-title>Unusual splice‐site mutations in the RSK2 gene and suggestion of genetic heterogeneity in Coffin‐Lowry syndrome</article-title>. <source/>Am. J. Hum. Genet.
<volume>70</volume>, <fpage>1421</fpage>–<lpage>1433</lpage>.<pub-id pub-id-type="pmid">11992250</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0131">
<mixed-citation id="jnc13723-cit-0131" publication-type="journal">
<string-name>
<surname>Zeniou‐Meyer</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Gambino</surname>
<given-names>F.</given-names>
</string-name>, <string-name>
<surname>Ammar</surname>
<given-names>M. R.</given-names>
</string-name>, <string-name>
<surname>Humeau</surname>
<given-names>Y.</given-names>
</string-name> and <string-name>
<surname>Vitale</surname>
<given-names>N.</given-names>
</string-name> (<year>2010</year>) <article-title>The Coffin‐Lowry syndrome‐associated protein RSK2 and neurosecretion</article-title>. <source/>Cell. Mol. Neurobiol.
<volume>30</volume>, <fpage>1401</fpage>–<lpage>1406</lpage>.<pub-id pub-id-type="pmid">21061166</pub-id></mixed-citation>
</ref>
<ref id="jnc13723-bib-0132">
<mixed-citation id="jnc13723-cit-0132" publication-type="journal">
<string-name>
<surname>Zheng</surname>
<given-names>L.</given-names>
</string-name>, <string-name>
<surname>Ding</surname>
<given-names>H.</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Ning</surname>
<given-names>T.</given-names>
</string-name> and <string-name>
<surname>Ke</surname>
<given-names>Y.</given-names>
</string-name> (<year>2008</year>) <article-title>E3 ubiquitin ligase E6AP‐mediated TSC2 turnover in the presence and absence of HPV16 E6</article-title>. <source/>Genes Cells
<volume>13</volume>, <fpage>285</fpage>–<lpage>294</lpage>.<pub-id pub-id-type="pmid">18298802</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>